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Abstract
Despite a large volume of research on the prognosis, diagnosis and overall burden of multimor-
bidity, very little is known about socio-demographic characteristics of multimorbid patients.
This thesis aims to analyze the socio-demographic characteristics of patients with multiple
chronic conditions (multimorbidity), focusing on patient groups sharing the same combination
of diseases. Several methods were explored to analyze the co-occurrence of multiple chronic
diseases as well as the associations between socio-demographics and chronic conditions. These
methods include disease pair distributions over gender, age groups and income level quintiles,
Multimorbidity Coefficients for measuring the concurrence of disease pairs and triples, and
k−modes clustering to examine the demographics of patients with the same chronic condition.
The experiments suggest that patient income quintile is not associated with multimorbidity
rates, although gender and age group may play an important role in prevalence of multimor-
bidity and diagnosis of certain disease combinations.
Keywords: multimorbidity, pairwise disease association, multimorbidity coefficients, k−modes
clustering, data mining
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Chapter 1
Introduction
Multimorbidity occurs ten to fifteen years earlier in people living in areas with socioeconomic
deprivation [4]. Research also suggests that the number of people with multiple chronic condi-
tions will increase in coming years [3]. Additionally, patients with more than one disease are
not only more likely to be diagnosed with new diseases and mental health disorders, they also
have higher levels of psychological distress, significant loss of function, higher utilization of
overall health-care, poorer mental health and quality of life, and limited physical functioning
and limited ability to work [4, 45, 52, 106, 108, 126]. However, not all combinations of chronic
conditions have the same effect on functional status of the patient. Specific combinations of
chronic conditions may lead to a greater risk of disability for patients [47].
This chapter provides an overview of and basic definition of chronic diseases, comorbidity,
multimorbidity, and the possibilities due to which two diseases may co-occur. It also defines
the research goals and plans for this thesis, as well as the anticipated strengths and challenges.
The outline of this dissertation is presented in the final section of this chapter.
1.1 What Happens When Chronic Diseases Co-occur
This section provides the definition of the basic concepts associated with chronic diseases, their
co-occurrences and effects.
1
2 Chapter 1. Introduction
1.1.1 Definition of Chronic Disease
A disease is defined as chronic if it lasts for a relatively long period of time and is irreversible
without any complete recovery [92]. The complete list of chronic diseases can be found at
International Classification of Diseases (ICD), which is a clinical cataloging system to classify
and code all diseases [81]. The ICD was developed to identify trends and statistics of health.
It is a classification standard for clinical and research purposes to identify diseases, disorders,
injuries and other related health conditions [93].
The diagnosis of a disease starts by indication of symptoms, risk factors and relevant anal-
ysis obtained by physical examinations. The treatment process is a stepwise approach with
regular control of patients’ laboratory analysis results, symptoms and signs [76]. Currently,
most of the medical knowledge is available for a single condition, and it may not be fully
applicable and acceptable for patients with multimorbidity1. Therefore, during the treatment
process of one disease, the efficiency of treatment of other disease(s) might be affected.
Characteristics of chronic conditions
Chronic conditions have nine characteristics: etiology, duration, onset, recurrence/pattern,
prognosis, sequelae, diagnosis, severity and prevalence [92].
Etiology: Sometimes it is not easy to define the etiology of a chronic condition. In some
cases, the presence of confounding factors may lead to a non-linear relationship between the
exposure to a pathogen and the presence of disease. These confounding factors may include
exposure to behavioral risk factors, such as smoking, poor nutrition and excessive alcohol con-
sumption, as well as genetic and environmental factors [75, 82].
Duration: Duration of a chronic disease is one of the characteristics of chronic conditions
widely used for defining the recovery time of conditions. There are three main time durations
1The term “Multimorbidity” is defined in section 1.1.2
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when defining chronic conditions: 3 months, 6 months and 12 months. Some studies rely on 3
months duration and reject 12 months when categorizing chronic conditions [94], while others
reject 3 months duration for classifying a disease as chronic condition, as they believe that
some acute conditions with lengthy recovery times will be classified chronic by mistake [110].
In the majority of studies, the duration of a chronic condition is defined to be at least 6 months,
as in [24, 65]. However, it is suggested that no standard duration can be applied to a chronic
condition, because the actual duration of a chronic condition is unique. It depends on the con-
dition itself and the person experiencing the condition [22].
Diagnosis: Although the diagnosis can be a defining characteristic of a chronic condition,
it is not the only indicative of all perspectives of a chronic condition and basing the definition
of chronic conditions on diagnosis might under-represent the prevalence of chronic conditions,
as some patients might have conditions that meet the criteria for diagnosis, but are not given a
chronic label [111]. However, in this research, the two terms of being diagnosed with a disease
and having a chronic condition will be used interchangeably.
Onset: The onset of chronic conditions is insidious and gradual. Patient’s age can be one
of the relevant aspects to onset of chronic conditions [110, 111].
Recurrence/pattern: The patterns of chronic conditions have wide variation both between
and within conditions. Some conditions have a deteriorating course, while some others are
episodic [22, 110].
Prognosis: While the main focus of prognosis is placed on the management of the condi-
tion and quality of life [30], lack of certainty for cure, incurability and poor prognosis are also
concerns discussed in studies regarding chronic conditions [22, 94].
Sequelae: According to “Dorland’s Illustrated Medical Dictionary”, the term “sequelae”
stands for physical or mental consequences that are caused by, or follow the course of a con-
dition [117]. Sequelae affects patients’ quality of life by adding physical disabilities, limita-
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tions of activity, reliance on medication or technical devices, or an increased need for medical
care [55, 94, 110].
Severity: The severity of a chronic condition may change continuously over the course of
the condition, and it depends on the stage of the condition [30]. Studies claim that conditions
where the severity of a disease, is not keeping the patient from daily functioning, and has a little
effect on patients’ physical or mental well-being, should not be included in the classification of
chronic conditions [94].
Prevalence: According to a study in general practice, a disease is classified as chronic only
when its prevalence is relatively high in the population being studied. However, this approach
has been disputed by some other studies where the chronic conditions are classified as chronic
if their prevalence is relatively low. In this case, the overall prevalence of chronic conditions is
the purpose of study [94].
1.1.2 Defining Comorbidity and Multimorbidity
In the medical literature there are several definitions and interpretations for the two terms co-
morbidity and multimorbidity. These two terms were used interchangeably by many authors for
a long time [44]. Researchers have compared the definitions of these terms in a large number
of relevant papers and their results show that the definition of comorbidity and multimorbidity
are ambiguous [119]. According to some definitions, coexistence of several diseases is called
comorbidity, while some other definitions claim that coexistence of other conditions with re-
spect to an index disease is called comorbidity [119]. In our work we rely on the classical
definition for these terms. The term comorbidity was introduced in 1970 by Feinstein and is
defined as “co-occurrence of other medical conditions additional to an index disease”. In other
words, comorbidity refers to any distinct additional entity that has existed or may occur during
the clinical course of a patient who has the index disease under study [39]. In this definition,
index disease refers to the primary disease or disorder under study. The additional clinical
entities (diseases or disorders) may occur or exist during the clinical course of index disease.
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Figure 1.1 shows the conceptual diagrams of comorbidity and multimorbidity [13].
Figure 1.1: Conceptual diagram of comorbidity and multimorbidity
Multimorbidity is a more recently introduced term in chronic disease epidemiology and is
defined as “co-occurrence of two or more medical conditions within a person, where one is not
necessarily more central than the others” [119].
There are two major considerations in the chronological analysis of comorbidity and multi-
morbidity: time span and sequence. The former discusses the span of the time across which the
patient has been diagnosed with two or more conditions. There has been less interest in con-
ditions which happened at the same point in time than conditions co-occurring across a period
of time [12]. The latter addresses the sequence in which comorbidities appear. The order of
diseases a patient is being diagnosed with plays a very important role in patient characteristics,
although from a cross-sectional perspective two patients may have the two exact same chronic
conditions. For instance, a patient diagnosed with hypertension who develops diabetes may be
very different from a patient with diabetes who is later diagnosed with hypertension.
1.1.3 Morbidity Burden and Patient’s Complexity
Morbidity burden is defined as the overall impact of the different diseases on an individual, tak-
ing into account disease severity. Patient’s complexity is a more broad perspective, considering
the morbidity burden while taking into account other health-related attributes. To make these
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definitions more explicit, consider the following example:
A 60-year old woman suffering from hypertension, depression and heart failure, who is
from an immigrant family living in Canada with limited skills in English, and who is also
taking care of a son with multiple sclerosis. Her cardiologist, focusing on her heart failure,
would consider her depression and hypertension as comorbidities to the index disease heart
failure. Her primary care physician will treat her hypertension, depression and heart failure
equally and will describe them as multimorbidity. Her morbidity burden would be shaped by
the presence of all chronic conditions the patient is diagnosed with, taking their relative severity
into account. Her complexity would be determined considering her health condition, i.e. her
chronic diseases, her immigration background, English language skills and fluency and her role
as a caretaker for her son (Figure 1.2) [118].
Figure 1.2: Comorbidity Constructs
There are three main areas where comorbidity and multimorbidity constructs are being
measured; clinical care research, epidemiology and public health, and health services and fi-
nancing. In each criteria, certain morbidity constructs are the area of interest for research and
computational purposes.
From a clinical research perspective, patient’s complexity is relevant to individual’s con-
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struct of comorbidity, where the index disease gets the highest priority. Patient’s complexity is
a newly emerging comorbidity construct, which acknowledges the influence of morbidity bur-
den not only by health-related construct, but also by patient behavioural characteristics [99].
In this perspective, although the focus is explicitly on the patient as a whole, the morbidity
burden becomes the more reliable construct to be considered. In this context, all conditions of
a patient are being given the same privilege.
From an epidemiological and public health perspective, the major focus is on the causes
of concurrent diseases. Therefore, both comorbidity and multimorbidity approaches will be of
interest in this context.
From a health services and financing perspective, estimation of costs for patient treatment
will not be calculated as sum of the costs for every single condition the patient has. Depending
on a patient’s condition and outcomes of interactions among co-occurring diseases, this cost
can be either greater or less than the sum of separate costs. Therefore, patient complexity plays
an important role in cost estimation in this area [118].
1.1.4 How Do Diseases Co-occur?
Diseases can be observed to co-occur due to three main reasons: chance, selection bias, or one
or more types of causal association.
Disease co-occurrence by chance
When diseases co-occur by chance, there is no etiological association between them. If we
assume x% of individuals in a population are affected with disease A and y% of them are af-
fected with disease B, then (x/100) · (y/100) of individual will have both x and y. There are
two assumptions made in this context: probability can be assigned to any disease, and the prob-
abilities of disease occurrences are independent in an individual who is suffering from more
than one disease. This factor of measurement only applies to diseases that have no associations
between their risk factors. In other words the rAB = 0 where rAB is the risk factor of A and risk
factor of B. Another name for referring to disease co-occurrence by chance, is coincidental
comorbidity, or random comorbidity.
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Disease co-occurrence by selection bias
Assume that a hospital wants to conduct a study where the goal is to estimate the association
between the occurrence of two diseases D1 and D2. For doing so, a control-case study is
conducted 2. In the study, hospitalized patients are considered as cases if they have D2 and
controls if they have D3. The prevalence of disease associations then will be calculated by
comparing the prevalence between D1 with cases D2 and with controls D3. The results show
that although there is an association between D1-D2 and D1-D3 in hospitalized individuals, the
association were null in source population.
As a conclusion, two diseases that are independent in the general population may become
“seriously associated” in hospital-based case-control studies, and the reason is higher hospi-
talization probability for patients with more than one disease - even if the diseases have no
association [7, 107]. In other words, clinical samples are not random samples from all people
in the general population. Individuals in clinical databases have more severe and greater num-
bers of symptoms than the ones in general population [97]. Although, this bias can be avoided
by using community samples rather than clinical databases [118].
Disease co-occurrence by causal association
According to Neale and Kendler [87], comorbidity can be categorized into thirteen models.
Table 1.1 provides a brief description for each of these models. One of the categories among
the thirteen models is “co-occurring by chance”, which was covered in previous sub-section.
The twelve remaining categories will be described in this subsection.
In Alternate Forms (AF), the co-occurring disorders are alternate manifestation of a single
liability. In Random Multiformity (RM) model, the risk factors for disorders are not associated,
but each one of them can increase the probability of the other disorder to increase. Extreme
Multiformity (EM) is a specific form of Random Multiformity, where the effect of risk factors of
each disorder is extremely high; if the individual has one of the disorders, probability of having
the other disorder is almost equal to one. In multiformity models the hypothesis is the idea
2Control-case study is a study which compares patients who have a disease or outcome of interest (cases)
with patients who do not have the disease or outcome (controls), and looks back retrospectively to compare how
frequently the exposure to a risk factor is present in each group to determine the relationship between the risk
factor and the disease [77].
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that comorbidity between two disorders occurs because being affected by one disorder directly
increases the risk for having the other disorder [87, 97]. In Three Independence Disorders (TD)
the presence of the diagnostic features of each disorder is actually due to its specific risk factors.
Correlated Liabilities (CL) refers to a group of disorders where the risk factors for each disorder
are associated while Reciprocal Causation (RC) refers to a group of disorders where one of
the disorders may cause the others. The difference between Reciprocal Causation (RC) and
Correlated Liabilities (CL) models is that, in RC models genetic and environmental risk factors
are united into a common latent phenotype before causation, whereas in CL model, no such
combination between the genetic and environmental risk factors has occurred before causation
[97]. Figure 1.3 shows a simple diagram of main causal association models described by Neale
and Kendler:
Figure 1.3: Major models of comorbidity between disorders A, B and C. A=disorder A;
B=disorder B; C=disorder C; RF stands for Risk Factor
According to Neale and Kendler’s comorbidity models, existence of a certain disease or
condition, does not necessarily cause the other. That is, “association does not necessarily
imply causation” [20].
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Name Description
Alternate Forms (AF) The disorders are comorbid because they are alternate
manifestation of a single liability. In this category in-
dividuals have disorder A with probability p(A), disor-
der B with probability p(B) and both disorders A and
B with probability p(A)p(B)
Random Multiformity (RM) Individuals who have disorder A, have the risk of dis-
order B increased by pA. Individuals having disorder
B, have the risk of disorder A increased by pB.
Random Multiformity of A (RMA) Submodel of RM where pB = 0.
Random Multiformity of B (RMB) Submodel of RM where pA = 0.
Extreme Multiformity (EM) Individuals who have disorder A, will have disorder B
and individuals who have disorder B, will have disor-
der A.
Extreme Multiformity of A (EMA) Submodel of EM in which only individuals who have
disorder A, will have disorder B and not the other way
around.
Extreme Multiformity of B (EMB) Submodel of EM in which only individuals who have
disorder B, will have disorder A and not the other way
around.
Three Independent Disorders (TD) The comorbid disorders are separate from either dis-
order occurring alone.
Correlated Liabilities (CL) Two disorders are comorbid because their risk factors
are associated. The relationship between risk factors
of disorder A and risk factors of disorder B is greater
than zero (rAB > 0).
Reciprocal Causation (RC) Comorbidity between two disorders occur because
two disorders cause each other. In other words, dis-
order A and disorder B cause each other in a feedback
loop.
A Causes B (ACB) Submodel of RC where disorder A cases disorder B
but not the other way around.
B Causes A (BCA) Submodel of RC where disorder B cases disorder A
but not the other way around.
Table 1.1: Alternate models of comorbidity between disorders A and B. rAB = the association
between risk factor of disorder A and risk factor of disorder B.
1.2 Problem Definition
Given disease combinations in patients, one question that arises is what might be similar among
people who are sharing same diseases? Are they of the same gender? Do they belong to the
same age group? Are they from the same ethnic group? Are they coming from a similar socio-
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demographic background? What similarities or differences can be found in their life style and
quality of life?
To the most part research is focused on identifying causes and effects of a single disease,
and as there is very little known about differences and similarities among patients who have
more than one disease. Although fully realizing this goal still has a long way to go, in this
research we are taking a step forward by exploring and identifying methods that may be used
to shed light on socio-demographic characteristics of patients with multiple chronic conditions.
This includes investigating various statistical and clustering methods which can efficiently be
applied for examining patients’ socio-demographic characteristics in terms of their similarities
and differences, as well as approaches to visualize the data of multimorbid patients and their
relationships.
Starting from identifying patients in our database with multimorbidity, we also need to
identify socio-demographic information associated with those patients. Besides performing
statistical measurements such as total disease counts and pairwise disease associations, we will
apply clustering algorithms to identify the similarities among patients who share same chronic
diseases and determine whether or not the factors we have extracted as socio-demographic
information are related to multimorbidity in terms of affecting multimorbidity.
There are three anticipated challenges for this research: (1) Limited availability of so-
cioeconomic variables for patients data; (2) Limited generalizability of the research results
to national population; and (3) Limited patient data over a long time span. The first antic-
ipated challenge means that we must contend with incomplete/missing variables for patient
data which limits the project scope because it limits the availability of correct/accurate data to
work with. Collected data becomes smaller in size with selection of complete and free of error
instances to increase the level of accuracy of the research, and on the other hand the availabil-
ity of sociodemographic information, such as patient ethnicity, languages they speak, income
level, education level, etc., is very limited. Specifically, in the DELPHI database3, which is the
source of data used in this research, these variables were absent for almost all patients existing
in the database. For this research, patient age, gender and residential codes will be used for
analysis purposes; the lack of all other socio-demographic variables represents a significant
3The definition and detailed information about DELPHI database can be found in Chapter 3.
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limitation on the scope of the project. The second anticipated challenge impacts the generaliz-
ability of research outcomes to a national population, as the DELPHI database does not contain
data from health care providers nationally. The third challenge means that the work must con-
tend with a lack of data for each patient over time. Information such as when a patient was
first diagnosed with a certain disease, what is the order of diseases the patient got diagnosed
with over time, how long was the time period between the diagnosis of diseases, what was the
patient’s socioeconomic status when the diseases appeared for first time, would allow us to do
more in-depth analyses. This would also allow the research to identify potential factors that
might impact diseases and which ones are being affected due to diagnosis of multiple chronic
illnesses.
The initial basis for this research is data on frequently occurring combinations of multi-
ple chronic diseases from a different research project [90], where disease combination counts
have been derived from a larger data source (the CPCSSN database4). Having access to this
information derived from a greater population size ensures the reliability of results to some
extent, and allows us to do further research on patient characteristics of those diagnosed with
commonly occurring disease combinations.
1.3 Outline of This Thesis
In this research we will elaborate on measurement and analysis approaches of multimorbid-
ity. To do so, we review the available methods for measuring and analyzing the burden of
multimorbidity and its relationship with a patient’s socioeconomic status in life.
Chapter 2 consists of three main sections. The first section describes how to measure mul-
timorbidity by applying existing statistical and clustering methods. It mainly focuses on most
frequently used pairwise association measurement methods and commonly used clustering
methods for clustering chronic diseases; describing how each one is calculated, and the ad-
vantages and weaknesses of them. The second section of Chapter 2 is dedicated to illustration
of multimorbidity indices (which are scoring tools for existing diseases within a person along
4The definition and detailed information about CPCSSN database can be found in Chapter 3. This data source
contains a total of 600265 electronic patient records as of data extraction period (September 30, 2013).
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with their severity degree) and challenges associated with them. This section concludes with a
brief introduction to four most commonly used indices developed for measuring outcomes like
subsequent risk of mortality, prediction of hospital re-admissions after getting a prescription
and health-related quality of life. The final section of Chapter 2 focuses on the influence of
socio-economic factors on the burden of multimorbidity among patients, and its association
with a patient’s age, gender, race and ethnicity.
Chapter 3 introduces the database used for analysis in this research. This Chapter describes
when and how the database was created, how often it gets updated, the number of records it
holds, the features and the coding strategies used for de-identification of existing records. The
Chapter also includes the description of the data extraction process, including identification of
missing values, data cleaning and strategies applied for dealing with missing data. It concludes
with the representation of a data table created from the database after data extraction and pre-
processing steps.
Chapter 4 describes the data analysis. It presents the results of statistical and clustering
techniques used for analyzing the relationships between socioeconomic status and two/three
coexisting diseases among patients sharing the same chronic diseases. The first section of
this Chapter focuses on analytical results of statistical multimorbidity measurement methods
explained in Chapter 2 for two coexisting chronic diseases. The second section describes the
clustering method used for clustering patients with two coexisting diseases. The clustering
algorithm was performed separately on all patients who share the same pair of diseases and for
most commonly occurring disease pairs. Some modification have been made to the algorithm
in order to adjust it for the data set, as well as the outputs and results of the algorithm, which is
also described in this section. The third and final section of this Chapter describes the results
for analysis of three coexisting diseases. As the counts for combination of three coexisting
diseases were far less than counts of two coexisting diseases, not all measurement methods
applied on diseases pairs were applicable for three coexisting diseases. Therefore, this section
only includes statistical distribution results.
The final Chapter summarizes and concludes the research and its final results. Research
strengths, limitations and recommendations for future investigations in the area of multimor-
bidity are also represented in this Chapter.
Chapter 2
Approaches to Measurement and Analysis
of Multimorbidity
2.1 How to Measure Multimorbidity
Determining the prevalence of co-occurring diseases in certain population groups has always
been a research need. The most straightforward approach for measuring multimorbidity is
counting the co-occurring diseases among individuals, which is discussed in the first part of this
section. More complex approaches try to find some kind of association among diseases. The
second part of this section, is mainly focused on measuring the association of disease pairs. The
methods described in this part are odds ratios, risk ratios, multimorbidity coefficients, Kappa
statistics and concordance statistics.
2.1.1 Total Disease Counts
The most straightforward way to measure multimorbidity is to count the number of diseases
for each individual in a group and then calculate the average number of diseases per person by
age. This approach can be used in research to determine the prevalence of multimorbidity in a
certain age group. For instance,Van den Akker et al.[120] have used this method to determine
the prevalence of multimorbidity in the elderly for the Dutch population. Due to the exponen-
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tial nature1 and discrete values derived from disease counts, any regression method works for
calculating the total burden of multimorbidity. Lappenschaar [76] found that there was approx-
imately one disease at age 40 and five at age 80 in the Netherlands. However, this method is
very coarse and does not provide much information about the distribution of diseases and their
association with factors other than age. Therefore, in order to gain more insight, other metrics
are used.
2.1.2 Pairwise Association
When diseases are to be compared in pairs, there are several ways to express their association.
Some of the measurement methods for pairwise association are described in the following.
Odds Ratios
One of the most widely used methods is using odds ratios to figure out the association between
two disorders. Odds ratios are commonly used in case control studies, however, they can
also be used in cross-sectional and cohort studies [102]. Their popularity is due to ease of
calculation and good estimation of relative risks [5].
Disorder 1 (D1)
Presence Absence Total
Disorder 2 (D2)
Present a b a + b = R1
Absent c d c + d = R2
Total a + c = C1 b + d = C2 a + b + c + d = N
Table 2.1: All possible observations for two arbitrary disorders occurring in an individual
For disorder D1 and disorder D2 the odds ratios is a quantitative measurement method
defined as the odds of being exposed to disorder D2 if one has D1, divided by the odds of
being diagnosed with D2 if one does not have D1. Table 2.1 shows all possible combinations of
two arbitrary disorders D1 and D2, where every cell shows the prevalence of occurring (or not
1The results of disease counts from several researches show that the number of co-occurring chronic diseases
within an individual drops very fast, as the number of diseases increase. That is the reason why the term expo-
nential nature for chronic disease count is being used. Due to the exponential nature of co-occurring diseases, it
is very challenging to figure out the association between diseases among patients diagnosed with more than three
or four diseases, as the available data for them is negligible, regardless of the collected database.
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occurring) of the corresponding disorders. According to Table 2.1, the odds of being exposed
to D2 if one has D1 is
a
c
, and the odds of being exposed to D2 if one does not have D1 is
b
d
.
Therefore, the odds ratios (OR) of D1 and D2 is calculated as follows:
OR =
a
c
b
d
=
ad
bc
(2.1)
This means that if a patient is exposed to D2, he is OR times more likely to have D1 than
if he is not exposed to D2. Odds ratios are used to determine whether a particular exposure is
a risk factor for a particular outcome [102]. Many major studies on psychiatric comorbidity,
such as National Comorbidity Survey of United States [70], the National Psychiatric Morbidity
Survey of Great Britain [62], and The Netherlands Mental Health Survey [8], are using odds ra-
tios for quantifying comorbidity. The association of narcolepsy (a neurological disorder) with
many psychiatric disorders has also been discovered using odds ratios [34, 46].
Odds ratios can also be modified to accommodate other patient demographics, such as
their gender, age, education level and other factors, using logistic regression. An example of
using odds ratios with additional patient demographics can be found in a study identifying
multimorbidity patterns in elderly performed in Stockholm [80].
Risk Ratios
Risk ratios (also called as rate ratios or relative risks) is another popular method for quantifying
association among two disorders, which calculates the ratio of the risk of occurrence of a
disease among exposed group of people to that among the unexposed [11]. Risk ratios are
not symmetric, therefore they can be defined for both diseases. According to Table 2.1, the
relative risk of D2 associated with D1 (RRD1), is defined as the risk of occurrence of D2 among
individuals who are exposed to D1, divided by the risk of occurrence of D2 among individuals
who are not exposed to D1. So, the risk ratio will be calculated as following:
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RRD1 =
a
a + c
b
b + d
=
a(b + d)
b(a + c)
=
aC2
bC1
(2.2)
Similarly, the risk ratio of D1 associated with D2 will be defined as:
RRD2 =
a
a + b
c
c + d
=
a(c + d)
c(a + b)
=
aR2
cR1
Risk ratios are used in assessing the likelihood that an association represents a causal rela-
tionship [11]. Risk ratios are widely used in psychiatric epidemiology [5].
Odds ratios are very similar to risk ratios, particularly in less prevalent diseases. Accord-
ing to Table 2.1, if a disease is rare, it will occur among very few individuals in a population,
therefore, b + d ≈ d and a + c ≈ c. This results that, OR ≈ RR in rare disease cases.
Multimorbidity Coefficients
Another commonly used method for measuring pairwise association is the use of a multimor-
bidity coefficient (also known as cluster coefficient or CC), which is defined as the division of
observed rate of co-morbidity (multimorbidity) by the rate which is expected under the null-
hypothesis of no substantive association between the separate disorders [5]. According to Table
2.1, the observed rate of comorbidity/multimorbidity, is
a
N
, and the expected rate of association
is
a + c
N
· a + b
N
. Therefore the multimorbidity coefficients (MC) will be calculated as follows:
MC =
a/N
[(a + c)/N] · [(a + b)/N] =
aN
(a + c) · (a + b) =
aN
C1R1
(2.3)
Odds and risk ratios can calculate the overall association among two diseases, but they can-
not separate non-random comorbidity (disease co-occurrences by causal association) from co-
incidental(random) comorbidity, neither can they measure directly the amount of co-occurrence
18 Chapter 2. Approaches to Measurement and Analysis of Multimorbidity
among pairs [5]. According to the example explained in Quantifying psychiatric comorbid-
ity [5], all three measures of OR, RR, and MC are equal to one if the association between
disorders is only coincidental, which indicates that the two disorders are not associated and
cannot be clustered in the same cluster. However, when there is an association among diseases,
MC shows a relatively smaller value compared to other two measures. Also, the more the
prevalence among two disorders increases, the difference between MC and the two other mea-
sures grows bigger, and the odds ratios value becomes progressively larger than the risk ratio.
The fact that measures of association diverge increasingly in OR and RR when the prevalence
of disorders rises, makes the two measures not appropriate to be used for sicker populations or
large populations. Because in sicker (or large) populations, the average number of disorders
within a person is higher compared to a relatively healthier population, and as long as the two
measures of associations are calculating the prevalence according to the population, they will
show a very high prevalence among majority of disease pairs. For more details, refer to the
original paper [5].
Odds ratios and risk ratios can only show the association between pairs of disorders, while
multimorbidity coefficients can express association among any number of diseases by dividing
the actual rate of multimorbidity by expected numbers of cases. Although calculating the
expected rate is a tedious process due to the very large number of combinations which should
be considered. To be more specific, if there are n disorders in a population, each with a different
prevalence (aka p1, p2, ..., pn), and the goal is to find the association of any k disorders (k ≤ n),
the number of combinations for expected rate of associations will be the combination of n and
k:
C(n, k) =
(
n
k
)
=
n!
k!
(n − k)!
And the expected probability (Pe) for each combination will be the product of probabilities
of k disorders that occur, multiplied by the product of probabilities of the rest of disorders, if
they do not occur. If we arrange the n disorders the way that k disorders expected to occur are
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in first k spots, the expected probability of an individual combination will be:
Pe =
k∏
i=1
pi ∗
n∏
j=k+1
(1 − p j)
As it is shown above [120], it is possible, but laborious to calculate the association between
many diseases using multimorbidity coefficients.
Kappa statistic
Kappa is a statistical measure primarily used for assessing the degree of interobserver2 agree-
ment in the form of binary ratings (in our case, presence or absence of diseases), which can be
used for finding pairwise disease association. The advantage of statistical methods over other
pairwise association methods is that they can be adjusted to measure expected coincidental
(random) co-morbidity [89]. Kappa is defined based on the difference between actual observed
association and expected association by chance [121]. It is calculated as follows:
κ =
p0 − pe
1 − pe (2.4)
where, according to Table 2.1, p0 = (a + d)/N which relates to the observed proportion of
association of diseases, and pe = (C1R1 + C2R2)/N2, which relates to the expected proportion
of association by chance3. Kappa is standardized to lie between -1 and 1. If p0 = 1, its value
will be equal to one4, which is interpreted as complete association among diseases. A zero
2Interobserver: occurring between individuals performing the same and especially a visual task [85]. Studies
that measure the level of agreement between two (or more) observers should also consider that an agreement (or
disagreement) can simply occur by chance [121] among observers.
3As mentioned above, pe is the probability of both diseases occurring together. To calculate it, having the
prevalence of occurrence (and non-occurrence) of each disease, pe will be calculated as the sum of probabilities
of both diseases occurring together, and probability of neither of diseases occurring. According to Table 2.1 the
probability of occurrence of D1 and D2 is (a + c)/N and (c + d)/N respectively. Similarly, the probability of
non-occurrence of D1 and D2 is (a + b)/N and (c + d)/N respectively. Therefore pe will be calculated as follows:
pe =
(a + c)
N
.
(a + b)
N
+
(b + d)
N
.
(c + d)
N
=
C1R1 + C2R2
N2
4The value of p0 will be equal to 1, if and only if a + d = N. This implies that b + c = 0, and as long as b and
c can be zero or positive, they both have to be zero, to meet the requirements for p0 to be 1.
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value for Kappa, implies that p0 = pe, which means that the observed association is equal
to the expected association by chance. In other words, the co-occurrence among diseases is
exactly what would be expected by chance. A negative value for Kappa implies that there
might not be any association among disorders because the observed association rate is less
than expected association by chance [121].
Kappa Association level
<0 Less than chance
0.01–0.20 Slight association
0.21–0.40 Fair association
0.41–0.60 Moderate association
0.61–0.80 Substantial association
0.81–0.99 Almost perfect association
Table 2.2: Interpretation of Kappa
For judging any value between 0 (association based on chance) and 1(perfect association),
Table 2.2 can be used, which is a commonly cited scale that divides the interval into five groups
and assigns an interpretation to each group.
The main drawback with the Kappa coefficient is that it strongly depends on the prevalence
of diseases. In some cases the value for actual association of disease pairs and the value for
Kappa coefficient lead to paradoxical results5. The Kappa coefficient is not a reliable measure-
ment method for observations where either the two conditions have very high (or very low)
prevalence rates, or when the conditions have very different prevalence rates (one very high
and the other very low). However, Feinstein and Cicchetti have developed methods to resolve
the paradoxical behavior of Kappa [19, 40].
Concordance statistics measurement methods
For finding the association between two disorders, these methods compare every possible pair
of individuals in a medical data-set; for a population of N persons, it will be N(N − 1)/2 com-
5Assume that among 100 patients, 84 of them have disorders D1 and D2, 6 of them have D1 but do not have
D2, 9 have D2 but not D1, and 1 has neither of the disorders. In this case the actual association among disorders
(p0) is 85/100 which is considered high, whereas κ = 0.04, which according to Table 2.2 is interpreted as slight
association.
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parisons. In order to calculate concordance statistics, concordant pairs and discordant pairs
need to be calculated. For doing so, assume that p1 and p2 are a pair of arbitrary individuals
(patients) in a study population. This pair is concordant if diseases D1 and D2 are both found
exclusively in p1 or p2 (but not both). The number of concordant pairs in population is cal-
culated as P = ad (a and d are values specified in Table 2.1). A discordant pair is a pair of
patients who both have only one, but not the same disease. The number of discordant pairs
is calculated as Q = bc (b and c are variables from Table 2.1). The remaining pairs in the
population, which are not concordant or discordant, are called ties, which refers to pairs where
p1 and p2 both have at least one concurrent disorder, i.e. they both have either D1, or D2, or
both disorders. Tc, Tr represent the number of ties in column variables only, and row variables
only, respectively.
Somers’ D, Kendall’s Tau-b and Gamma are concordance statistics methods which can be
used for measurement of pairwise disease association.
S omers′D =
P − Q
min(Wr,Wc)
(2.5)
Kendall′sTaub =
P − Q√
WrWc
(2.6)
Gamma =
P − Q
P + Q
(2.7)
where Wr = P+Q+Tr and Wc = P+Q+Tc. The Gamma statistic ignores the tied pairs in cal-
culating the association which overestimates the strength of association when many tied pairs
are present in the study population [10]. In a study performed to identify co-morbidity patterns,
the four methods of Kappa coefficient, Somers’ D, Kendall’s Tau-b and Gamma have been
compared, and the study concluded that the Somers’ D and Kendall’s Tau-b have the best per-
formance among other measurement methods for identifying non-random co-morbidity [89].
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2.1.3 Clustering of Diseases
Clustering techniques are common approaches used to study aspects of multimorbidity, partic-
ularly to link psychiatric phenotypes to clinical measurements [76]. Some of the methods for
clustering individuals or variables in health-care projects are described in this section.
K-means Clustering
Clustering methods aim to partition data points into clusters such that data points in the same
cluster are more similar to each other than data points in different clusters according to some
defined criteria. The K−means clustering algorithm (first introduced by MacQueen in 1967) is
a vector quantization method which aims to partition data points based on Euclidean distance.
For a data set (x1, x2, ..., xn), where each data point xi for (1 ≤ i ≤ n) is a multi-dimensional
vector, k−means aims to partition n points into k, (k ≤ n) clusters or sets, in which each data
point belongs to the cluster with the nearest mean distance. The objective of k−means is to
minimize within cluster sum of squares defined as:
J =
k∑
j=1
n∑
i=1
‖x( j)i − c j‖2 (2.8)
Where J calculates within-cluster sum of squares for all clusters, and ‖x( j)i − c j‖ provides the
distance between a data point and it’s cluster’s centroid.
The algorithm is composed of the following steps:
1. Initialization: Define and place k data points in data space.
2. Assigning data points to clusters.
3. Recalculation of positions of the K centroids.
4. Repeat steps 2 and 3 until the number of data points moving between clusters falls bellow
a predefined threshold.
Two commonly used methods for initializing k points are Forgy method and random parti-
tion method [54]. The Forgy method randomly picks k points from data set and uses them as
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initial centroids6. In contrast to Forgy method, the random partition method starts from step 2
and assigns a cluster to each data point. Once the initial assignment is over, the centroids for
clusters are defined by computing the means of data vectors in each cluster.
After initializing the centroids, the algorithm proceeds to step 2, where every data point
gets assigned to its nearest cluster. To accomplish this, Euclidean distance between every
data point and all centroids is computed, and the data point is assigned to a cluster by the
smallest Euclidean distance. In step 3, the mean vector for every cluster is calculated and the
centroids of clusters are updated to the new mean vector. The algorithm iterates between steps
2 and 3, unless the number of data points which have been moved between clusters is smaller
than a predefined threshold or is zero. However, there is no guarantee that the algorithm will
converge to a global optimum7, the results depend on the initial centroids and how they are
being defined. On the bright side, practically the algorithm usually converges very fast despite
being computationally difficult (NP-hard)8, therefore it is possible to run the algorithm multiple
times with different starting points.
The main drawback of k−means is its cluster model. The concept of this method is based
on spherical clusters, such that the assignment of the nearest cluster is the correct assignment,
and clusters separating factor is their mean value (vector) converging towards the cluster center.
This limitation makes the selection of the optimal number of cluster (k) difficult for any given
dataset. Therefore, an inappropriate initialization of a data point as a centroid, might lead to
poor/inappropriate data space divisions.
One of the other limitations of the K−means clustering algorithm, is the nature of distance
based computations. Due to this, the algorithm is applicable only on numerical data types
and cannot be used for categorical data types. Different approaches have been introduced to
overcome this limitation: One of the traditional solutions is to convert categorical values into
6In mathematics and physics, centroid refers to the arithmetic mean or average position of all the points in the
space. A centroid in clustering algorithms, is a candidate data point in a cluster, which can be used as a measure
of cluster location. Therefore, every cluster carries one centroid as its representative. In k−means algorithm, the
data vectors of centroid c in cluster C for 1 ≤ C ≤ k, are created by computing the means of all data points in that
cluster.
7The global optimum is reached when the assignments of data points to clusters no longer change.
8Finding an optimal solution for k−means clustering problem in d dimensions is NP-hard in d−dimensional
space even for 2 clusters, and also for k clusters even in 2−dimensional space [2, 79]. In worst case, k−means can
be solved in O(ndk+1) [60].
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numeric values, which does not necessarily produce meaningful results [58]. Another approach
is the k−modes algorithm, which is a variation of k−means for clustering data sets of categor-
ical type. This approach is explained in detail in Chapter 4 section 4.1. The K−prototypes
algorithm is another approach which integrates k−means and k−modes and enables clustering
of data sets with mixed data attributes (numeric and categorical) [57].
Factor Analysis Techniques
Factor analysis techniques have been widely used in behavioural sciences. The basic logic of
factor analysis was first developed by Charles Spearman in 1904 [109]. Factor analysis is a
multivariate statistical method which aims to identify the factors or dimensions that underlies
the relations among a set of observed variables [73]. In factor analysis, an observed score for
person i measured at time j is Xi j which is made up of two components:
Xi j = Ti + Ei j
Ti is the true component and Ei j is the error component of Xi j. The error component is random
and unrelated to true component. Therefore, the variances in observed scores can be computed
as following:
σ2X = σ
2
T + σ
2
E
where σ2T and σ
2
E are non-overlapping parts and σ
2
T is the true variance which consists of com-
mon variance and specific variance. The common variance is shared among a set of indicators
and it appears due to effects of underlying factors. The specific variance is made up of unshared
variance of indicators and measurement error Ei j. Factor analysis methods aim to identify a
smaller number of factors that explain most of the common variance [73].
Factor analysis methods in general are useful for identifying groups of items that are
strongly correlated. There are two broad categories of factor analysis, Exploratory Factor
Analysis (EFA) and Confirmatory Factor Analysis (CFA). Exploratory factor analysis uses la-
tent variables to discover the correspondence of large sets of variables in a data set. In EFA, it
is assumed that any observed variable (indicator) can be associated with any number of factors
(a.k.a. latent variables). EFAs have been commonly used in research to identify clusters of
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chronic diseases (variables of data set) [56, 63, 72, 95]. Confirmatory factor analysis uses the
same approach as EFA, and hypothesizes the number of factors in the model before starting
the analysis. One of the applications of CFA in research is the work of Johnson and Wolin-
sky [63], where CFA was used to explore a model for multiple diseases, disability, functional
limitations, and perceived health amongst elderly.
Latent Class Analysis
The main goal in latent class analysis (LCA) is to find a reduced set of dimensions that explain
the relationship between variables. This method is similar to factor analysis methods (EFA and
CFA) in terms of discovering the structure of variable sets and different from these methods in
assuming that the latent variables are categorical. A latent class analysis defines membership
levels for latent classes and every set of attributes belongs to each latent class to some degree.
A complete overview of LCA can be found at the research of Schüz et al.[101], which aims
to use LCA to measure the subjective well being in later adulthood, and concludes that health
conditions in older adults can be divided into four groups: no disease, cardiovascular disease,
joint problems, and multiple illnesses.
2.2 Comorbidity and Multimorbidity Indices
In this section we define and discuss a research tool to organize, summarize, compare and
measure comorbidity and multimorbidity. This research tool is called an “index”. In most of
these indices, a group of diseases are selected and weighted, either according to their individual
severity [15], or their influence on other factors, such as mortality [18], quality of life [52], or
hospital stays [116]. There is a lack of agreement on the number and type of diseases to be
included in an index. Therefore, there is a large heterogeneity on number of diseases in a
certain index [31]. Some indices consider only a small subset of chronic diseases [83], and
some include up to 185 different diseases [64].
According to the definition of comorbidity and multimorbidity, the indices are designed
based on the research needs. In indices for multimorbidity, no index disease is defined or used.
Whereas, in comorbidity indices, defining an index disease is obligatory. Although, depending
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on the focus of the research (whether it is on measuring the total burden of disease, or the
burden of comorbid disease in addition to the condition of interest), some of the indices can be
used in both types of research. In the second case, the index disease is being treated/weighted
the same way as the other diseases, if the method is being used for multimorbidity [31].
Although there is no gold standard for the measurement of comorbidity or multimorbidity,
and the existing indices are too coarse to be replaced with clinical judgment in clinical decision
making, the numerous measurement methods and indices exist which can be used in health
research [4, 33, 53].
The main focus of this section is to focus on some basics of co/multimorbidity indices,
such as what they are, how are they being measured, when it is best to use them, and how to
measure an index’s validity, reliability, feasibility and generalizability [53]. For simplification
purposes, we refer to comorbidity and multimorbidity indices as co/multimorbidity indices.
2.2.1 Definition of a Co/multimorbidity Index
A co/multimorbidity index is a measurement tool which reduces all existing diseases and
their severity into a numeric score. This score can then be used to compare patients having
co/multimorbidities [53]. In every index, all morbidities that are being included in calculation
are given a weight. For some indices the same disease is given multiple weights based on its
severity. The final score for diseases is then calculated. Some indices assume that the impact
of diseases is additive [78], so their final score is the addition of weights of all existing diseases
within the patient which are included in the index disease list. Some other indices determine
the weight of single most severe index as the prognosis [66]. Therefore, a patient can get two
widely different scores from two different morbidity measurement indices due to three main
reasons: list of available diseases for an index, different weights associated to the same dis-
ease in different indices, different scoring system among indices. For co-morbidity indices the
score can vary for the same patient and same index, only by changing the disease of interest.
These indices are being used wherever it is needed to classify patients into groups with similar
risks [53].
An index is often designed based on researchers’ specific needs. The population for design-
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ing and testing the index is usually a specific group of patients being hospitalized because of
a certain condition. Therefore the development of a co/multimorbidity measure is influenced
by population and outcome used, and as a result, the weights assigned to diseases for an index
might be different if the population of the study was different [37].
Co/multimorbidity indices are predictive indices [53] which contain three main compo-
nents: items (morbidities), severity scales for items (weights), and a scoring system. Any
co/multimorbidity index should be assessed with following principles: content validity, face
validity, reliability, predict ability, feasibility, and generalizability. In following part of this
section, these terms are defined briefly.
Content validity is a term used for assessing the validity and completeness of items, as well
as the relevance of content of items to evaluate what they claim to measure. Content validity ex-
amines whether the items and their severity scales appropriately describe the co/multimorbidity
phenomenon and whether any irrelevant areas are included [53].
Face validity refers to the sensibility of the index and whether it can be used in general
clinical studies. The method used for the generation of items (judgmental, statistical, etc.)
and the weights assignment method (equal or weighted) are examples of two features for face
validity assessment. Most of the indices have not accounted for the validity of the scoring
system when it was developed and tested. Therefore, in a hypothetical index A, a score x for
hypertension, does not necessarily have the same impact as score x for asthma. In most of the
indices, the scoring system is made up based on assumptions. Furthermore, it has not yet been
proven that any index is superior to another one, or if any of them are more appropriate to be
used [53].
Almost all of the co/multimorbidity indices have been developed based on a specific pop-
ulation, in a specific time and place. Reliability refers to the extent to which the results of
the indices will be similar, by changing the population, the time and the place of the experi-
ment [42]. Due to the diversity of indices (i.e. list of items they each accept as input, system
of weighing every morbidity, scoring system differences, and the way they each deal with
common confusing situations such as unstated diagnosis when a person is taking a specific
medication, or uncertainty in diagnosis), it is almost always essential to define a unique set of
rules for every index to measure their reliability [53].
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Co/multimorbidity indices should be simple, easy to understand and use. Therefore the fea-
sibility is defined and it refers to the simplicity, ease of use, availability, training requirements,
and the time of administration of an index [53].
All the indices have been designed and tested on a specific group of patients (population).
It is important to decide whether the results gained from the study group when designing and
testing the index, are generalizable to other groups or not. Therefore, generalizability is an
important feature that should be examined when designing a new index.
2.2.2 Challenges Associated with Co/multimorbidity Indices
Almost all comorbidity and multimorbidity indices use ICD(International Classification of Dis-
eases) to create their list of items, and the different levels of disease abstractions in every index
further increases the variation and number of conditions, thus, the complexity of indices in-
creases when it comes to result comparisons. As an example “heart disease” can be categorized
as one condition referring to all problems and conditions related to heart disease (e.g. [122]), or
it can be categorized in a few different items (conditions), such as hypertensive heart disease,
ischemic heart disease, and rheumatic heart disease(e.g. [48]). Besides all the differences in
types of listing of the conditions, there are a few studies where the list of the items used in the
index is not included in the review (e.g. [64] or [78]). These studies are practically inefficient
either for being applied to different population groups, or further research for modifications
and development.
As mentioned earlier in this section, the heterogeneity in weighting methods among dif-
ferent indices makes it difficult to compare the results. The origin of this heterogeneity is
the different approaches the indices take for weighing the items. In some studies the weights
are used to analyze the effects of multimorbidity on objective outcomes, such as costs [116],
hospitalization [38], and mortality [18]. In some indices, morbidities are weighted according
to predefined criteria such as prescribed medicine [122] or clinical parameters [88]. In an-
other group of studies, weights are applied according to subjective outcomes, such as depres-
sion [27], and health related quality of life [15]. Future work on improving co/multimorbidity
indices would be to find a way to standardize weights for different indices, so that they would
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be easily comparable [33].
The data source used for designing most of indices is extracted from self-reports, and the
studies show that there is a poor agreement on data obtained from self-reports and medical
records [25, 67, 115]. Also, the population considered for designing and testing indices is bi-
ased mostly to older people because those are the ones with higher risk for morbidities. There-
fore, there might be some validity issues when using the indices for general population [33].
All these challenges aside, the question becomes whether it is possible to have an estab-
lished index which can fit to general population is various studies. Multimorbidity in reality is
more complicated than simply addition of a number of diseases; there are so many other fac-
tors affecting the phenomenon such as social, physiological, emotional and cultural factors, as
well as living condition, socioeconomic status and individual preferences in treatment strate-
gies. All these parameters are required to be considered in assessment of multimorbidity, and
it is not very straightforward to aggregate all these factors into a single number. Although, in
studies where morbidities are indicated with their severity, the goal of incorporation of various
factors has been partially achieved. Moreover, in recent studies, a few general questions are
added to the interviews to measure the extent of social, physical, and mental impairments, and
the results can be included in indices [33].
As mentioned earlier in this section, there are numerous indices available for measuring
multimorbidity and comorbidity. In the next subsection, we describe some of the most fre-
quently used indices for multimorbidity. More details on comorbidity indices can be found
in research of Vincent and colleagues in Amsterdam [31] and the research of Stephen Hall at
Queen’s Cancer Research institute in Canada [53].
2.2.3 Examples of Multimorbidity Indices
According to a systematic literature review study upon measurement methods of multiple
chronic diseases (e.g. [33]) performed in 2011, 39 multimorbidity indices have been identified
which analyze the association among multiple chronic diseases. Data sources for assessment
of indices are extracted from self reports, physician reports, medical records and administrative
data. Most of the indices are using hospitalized patients data from health maintenance organi-
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Figure 2.1: Multimorbidity Indices Conceptual Diagram
zations(e.g. [6]) and health insurance centers(e.g. [88]), as study population. However, veterans
and war widows have also been studied as population source in some indices (e.g. [15] or [38]).
Some of the well-known and frequently used indices which have used medical records, physi-
cian reports and administrative data as data sources, are introduced below briefly.
Charlson Index is the best known and most frequently applied method for classifying co-
morbid conditions (diseases) that might alter the risk of mortality [18]. The index calculates
the risk of mortality based on number and seriousness of diseases co-occurring within an in-
dividual. The data source for testing the index’s functionality and predictability is observed
from medical records of 685 patients who were treated for primary breast cancer. There are
18 chronic diseases being studied in this index: They are coded as 1 or 0, based on being or
not being present in an individual, respectively. The severity is coded as an integer number be-
tween 1 and 5, based on how severe the disease is. The unadjusted and adjusted relative risks
(risk ratios) of mortality are calculated. Unadjusted relative risks calculate the mortality risks
of patients having a certain condition, ignoring the other conditions that may coexist within
the individual. For a specific disease, unadjusted relative risk is calculated as the proportion
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of patients with the condition who died, divided by the proportion of patients without the con-
dition who died. The adjusted relative risks take into account the coexisting conditions that
may occur within the individual, as well as the conditions severity. A patients subsequent risk
of mortality is calculated by combining the adjusted relative risks and patients’ age, which is
used to predict the survival rate. The statistical difference between the expected and predicted
mortality rates is examined by chi-square test [18].
Medication-Based Disease Burden Index (MDBI) is a convenient method for quantifying
disease burden and predicting health outcomes using medication records and data on chronic
drug therapy [48]. The results from the analysis of MDBI consist of a table of 20 chronic
diseases, and drug classes corresponding to each one of them. There are weights associated
to each disease. If patient’s medication contains any of the agents listed in MDBI, the corre-
sponding weight will be assigned to patient, and the total score for the patient is the sum of
all weights associated to him. The results of MDBI tested on patients show that the scores
are significantly related to number of medications being taken at a time, and patients’ age, as
well as a decent predictor of death and planned or unplanned re-admissions during 12 week
period [48]. More details on the procedure performed for analysis methods used in the study
are described elsewhere (i.e. [48])
Index of Co-existing Diseases (ICED) is another famous index for multiple chronic disease
measurement. Potential candidates for the study, were patients older than 18 years of age, who
were discharged after having total hip replacement over the period of eighteen months. The
data was collected from four hospitals, and 356 patients were selected randomly among po-
tential candidates [50]. The main goal of examinations in ICED is to measure the impact of
baseline preoperative co-existing diseases on postoperative complications, which was proven
to be significantly high [50]. More details on the disease association measurement methods
and data analysis procedure can be found at the main paper explaining the index (i.e. [50]).
Nottingham Health Profile (NHP) is an estimation for health-related quality of life (HRQL),
where the presence of different symptoms (including physical, emotional and social indicators)
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and lack of ability in various basic activities (i.e. handicap and health-related problems in dif-
ferent life areas) is documented [59]. NHP was applied to patients of only 76 years of age, in
order to estimate their mortality risks. It is evaluating the outcome in two separate parts. The
first part displays the degree of discomfort or distress using six dimensions: lack of energy,
pain, emotional reactions, sleep, social isolation and physical mobility. The overall score for
this part of NHP is 6, and the higher the score, the greater severity the problems. The second
part of NHP contains seven polar questions (i.e. yes/no questions) regarding to occupation,
social and personal lifestyle, interests, holidays and hobbies [51]. The details about statistical
analysis can be found in the main paper (i.e. [59]). A modification of NHP has been used to
analyze HRQL of five hundred sixty five 76 years old citizens of Sweden (i.e. [51]). The results
indicate that older people accept being diagnosed with certain number of diseases and having
some disability as natural consequences of being old. Therefore, the health related quality of
life changes for elderly (in this study for a sub-sample of 76 years olds), such as they consider
themselves to have good HRQL even when they are diagnosed with certain conditions such as
hypertension, cancer, or lung disease.
Incalzi Index is an index used to predict the mortality of geriatric elderly patients with acute
medical illness by measuring the interaction between comorbidity and age of patients. The test
has been performed on 370 patients between 70 and 90 years of age who were consecutively
admitted in hospital in an 18 month period. The index consists of two sub indices: a comorbid-
ity index and an age-comorbidity index. The comorbidity index is based on a scoring system
which quantifies the prognostic weight of individual diseases, while the age-comorbidity index
increases mortality risk by accounting an age-related risk factor. In order to assign a weight to
each disease in the comorbidity index, active illnesses of each one of the 370 patients was listed,
and, according to relative risk of death for each person, the scoring system was developed.[61]
In the age-comorbidity index, an additional score of 0,2,3 and 4 points are added to patients
aged 66-75, 76-85, 86-95 years and over 95 years, respectively. Kappa statistical measure
is used to assess the reliability in computing the index of comorbidity[23]. More details on
complete list of analysis methods used to develop the index can be found in the main paper
(i.e. [61]).
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The indices introduced above are more commonly used measurement methods for predict-
ing health related quality of life or mortality risks. A full reference for all existing multimor-
bidity indices can be found in [33]. Unlike most of the existing multimorbidity indices which
use self reports as their data source, the data source of all indices introduced here are based on
medical records, and physician reports, which is assumed to be more reliable. The outcome of
Charlson index, Incalzi index and MDBI is mortality, while the goal of ICED is prospective
complications and NHP focuses on health related quality of life.
2.3 Impact of Socioeconomic Status on Diagnosis and Treat-
ment of Multimorbidity
As mentioned in previous chapters, various aspects can play an important role on onset of mul-
timorbidity, and socioeconomic status9 of the individual is one of them. Individuals with low
socioeconomic status are more likely to have diseases (chronic and acute), be physically and
mentally impaired and face partial or full loss of function [1, 98]. The influence of socioeco-
nomic status of health-related quality of life is assumed to begin in the prenatal environment
and continues throughout individuals life [14, Chapter 4]. For instance, childhood socioeco-
nomic differences have been shown to play a significantly important role in mortality gaps
later in life between blacks and whites [123]. The research of Dr. Barnett and colleagues
(i.e. [4]) reveal that multimorbidity occurs ten to fifteen years earlier among people with low
socioeconomic status. However, health and socioeconomic status (mainly wealth) have dual
relationships in the way that it is not only poor socioeconomic status which affects health; but
poor health conditions also affect socioeconomic status, as well. If someone is facing health
related problems which causes physical or mental distress, they often cannot be as productive
in their workplace as they would be if they did not have health issues. A self reported study in
9Socioeconomic status (SES) is an economic and sociological combined total measure of a person’s work
experience and their or their family’s economic and social position in relation to others, which can be based on
income level, education, and occupation. When analyzing a family’s socioeconomic status, household income,
earner’s education and occupation are examined. The SES index is a composite of often equally weighted, stan-
dardized components of parent’s education, family income and household items. The terms high, middle, and low
SES refer to ranges of the weighted SES composite index distribution [69].
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1999 shows that those with fair or poor self-reported health had less wealth growth compared
to others over the next ten years [105]. The various factors of socioeconomic status, their im-
pact on health of the individual and prevalence of multimorbidity are discussed in the following
sections of this Chapter.
2.3.1 Socioeconomic Factors and Their Impact on Health
Education, income level, wealth, occupational status, and residential neighbourhood are so-
cioeconomic factors which can affect individual’s health behaviors, diagnosis of diseases, and
health care services [71, 103].
In general, multimorbidity is less common in individuals with higher socioeconomic sta-
tus, and they are more likely to get access to treatments and be able to handle and afford the
treatment if necessary [49]. For instance, having high level of education (which is one of so-
cioeconomic factors) helps individuals to read and research more accurately about the health
conditions that they have or might be exposed to, which will help them to prevent the disease
or start and monitor the treatment in early stages of their diagnosis.
Socioeconomic factors have an affect on early diagnosis of most, but not all, diseases.
Socioeconomic deprivation does not change the prevalence of diagnosis of some chronic con-
ditions, such as cancer, skin diseases and kidney diseases [29]. However, the prevalence of
certain conditions, such as depression, drugs misuse, anxiety, dyspepsia, pain, CHD (coronary
heart disease), and diabetes is higher in people who are living in areas with high socioeco-
nomic deprivation [84]. According to the results of research performed by a group of medical
researchers in 158 general practices in Germany (i.e.[100]), the impact of education and in-
come levels on multimorbidity is as follows: Patients with medium or high education level,
had a mean of 0.3 diagnoses less than individuals with low education level [100], while aller-
gies have proven to be more common among them [29], and patients with higher net income
(or bigger household size), had 0.3 diagnoses less on average [100].
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2.3.2 Associating Multimorbidity with Socioeconomic Factors
One of the complications in measuring socioeconomic factors is that the same results for an
arbitrary socioeconomic factor may possibly signify something different among two different
population groups. For instance, when measuring income level, the absolute amount of income
cannot be interpreted as high if it is not being translated into same purchasing power for two
different communities. As another example, junior year high school students may exhibit dif-
ferent levels of knowledge if they are being trained in different countries, cities, schools, or
even communities [68, 125]. Whenever it is possible in studies, it helps to split the population
into smaller relatively consistent sub-groups and measure the factors separately.
Many studies have shown that socioeconomic factors (education, income, occupational
status, sometimes residential neighbourhood), play an important role in health conditions of
individuals. However, due to the reasons explained here, it is not straightforward to come up
with a standardized and uniform pattern of factors influencing health outcomes10.
Due to the dual relationship of socioeconomic status and health impairment, it is challeng-
ing to decide the lack of which one has caused the impairment of the other. People living in
poor socioeconomic status are more likely to have impaired health conditions, and not being
able to afford to pay off the health costs makes it even worse in the way that they do not get the
required treatments to overcome the condition with which they are diagnosed. For instance,
low income patients are at increased risk not only for developing asthma but also for reduced
access to appropriate care [86]. On the other hand, not being in good health can have a negative
impact on an individual’s career through missed workdays and in some cases work loss [35].
Race and ethnicity are other dominant factors which should be taken into account when
predicting the impact of socioeconomic status on health care. For instance, there is a higher
prevalence of hypertension among black men, and they experience significantly lower life ex-
pectancy compared to whites. Also, Hispanics and black men are more likely to have diabetes.
This ethnic and racial differences are not explained by socioeconomic status [28].
Levels of stress (it could be the work related stress of personal life related stress), differ-
10There are many population subgroups within larger population groups which may be affected by different
factors. For instance, Hispanics are known to have lower age-adjusted mortality rates despite higher poverty,
compared to whites. As another example, among socioeconomically same groups of people, blacks are more
likely to have hypertension, and blacks and Hispanics are more likely to have diabetes [28].
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ences in health care access, and behavioural risk factors (such as smoking, overeating, lack of
exercise, and excessive alcohol consumption) are other factors that need to be considered for
more precise results when studying health impairment factors [14].
2.4 Summary of Multimorbidity Measurement Approaches
Various aspects, causes, effects and measurement and computational approaches for under-
standing multimorbidity have been analyzed throughout this chapter. Multimorbidity has been
defined as the coexistence of multiple diseases within the same individual. Co-occurrence of
diseases can happen due to chance, or it can be due to causal association. In studies conducted
for measuring disease association rates or prevalence, selection bias occurs when clinical sam-
ples are used to conduct the study, and the reason is the relatively sicker source of population
being used for analysis purposes. In order to overcome this effect, the population of the study
should be selected from non-clinical samples.
Some approaches for measuring multimorbidity are: total disease counts, pairwise associa-
tion methods, disease clustering approaches and disease networks. The most common methods
used for pairwise disease association are, odds ratios, risk ratios, multimorbidity coefficients,
kappa statistics and concordance statistics measurement methods. The advantage of statistical
measures compared to non-statistical methods (odds ratio, risk ratio and multimorbidity coef-
ficients), is that they can be adjusted to measure expected coincidental rate of multimorbidity.
Among the three non-statistical methods, multimorbidity coefficients was proven to have linear
behavior when the prevalence of disorders rise, while the other two measures have an expo-
nential raise as the prevalence of multimorbidity rises, which makes them not appropriate to be
used for sicker populations.
Using disease networks to represent diseases and their associations is a relatively more re-
cent approach for visualizing the association among diseases. In disease networks, diseases are
represented as nodes, and their associations are represented by undirected edges [76], where
each edge drawn between a pair of nodes (a pair of diseases), is showing the association be-
tween that pair of diseases. The association rate can be calculated using any of the pairwise
association measurement methods (i.e. multimorbidity coefficients). However, when the asso-
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ciation between two diseases is caused due to a third disease, this approach cannot be used.
The impact of socioeconomic deprivation was another topic discussed in previous chapters.
It was discussed that certain diseases have higher prevalence among individuals living in more
deprived areas with lower socioeconomic status. However, besides socioeconomic factors,
race and ethnicity are many other factors which make differences in prevalence of diseases;
The influence of race, ethnicity, age-adjusted mortality rates, levels of stress, feasibility of
access to health-care centers and many other factors on individuals health, makes it impossible
to conclude a general statement about the importance of particular socioeconomic factors.
This chapter has also introduced multimorbidity indices which are used for measuring mul-
timorbidity. Despite the numerous multimorbidity indices being introduced over time, there is
no gold standard for measuring the complex phenomenon of multimorbidity, because the idea
of summarizing the complex reality of multimorbidity into a single indicator, which is the gen-
eral process for a multimorbidity index calculation, makes the further decision making prone
to external criticism.
As mentioned in section 2.3, socioeconomic status of the individual can play an important
role in diagnosis, prognosis and treatment of chronic diseases. One purpose of the research
addressed in this thesis is to analyze the impact of socioeconomic and socio-demographic fac-
tors on patients diagnosed with multiple chronic diseases. To accomplish this goal, we have
collected the available socio-demographic information of patients from the DELPHI database,
and analyzed them using some of the approaches introduced in this chapter. Disease associ-
ations, their distribution over gender, age group or socioeconomic score, and the impact of
socio-demographic factors on groups of patients sharing the same diseases are analyzed using
three main approaches: (1) statistical analysis methods have been used in order find the dis-
tribution of individual diseases and disease pairs over gender, age groups and socioeconomic
status pf patients, (2) pairwise association methods have been applied for measuring the asso-
ciation of disease pairs in the database and (3) a variation of k−means algorithm introduced
in sub-section 2.1.3 has been implemented in order to find clusters among patients sharing the
same diseases for the most commonly occurring disease pairs.
Chapter 3
Data Collection
3.1 The Database
The DELPHI (Deliver Primary Healthcare Information) project started in 2003 with the goal of
creating a primary health care researchable database derived from electronic medical records
(EMR)1 of ten primary health care practices throughout Southwestern Ontario. The project
is based in the Centre for Studies in Family Medicine (CSFM) in the Department of Family
Medicine, University of Western Ontario. The current version of the database de-identified
data from ten practices and includes around 30,000 patients [113].
The Canadian Primary Care Sentinel Surveillance Network (CPCSSN) project started in
2008 with the goal of developing a network to collect health-related information from patients
with chronic diseases across Canada. It is Canada’s first multi-disease surveillance system
based on primary care EMR data [112]. Initially, the network began amalgamating data nation-
ally from seven existing academic research networks in Calgary, Edmonton, London, Toronto,
Kingston, Montreal and St. John’s. Later the network was also developed in Winnipeg , Hali-
fax and Vancouver. CPCSSN database currently holds the data of ten practice based research
networks and it contains the medical records of over one million patients. Patients’ health in-
formation is being extracted from these networks, cleaned and coded into CPCSSN database
every three months [9].
1The term electronic medical record is used to describe electronic patient’s records that are being kept in one
location and are accessible by only one provider’s site [114]
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DELPHI database is one of the several networks included in the CPCSSN project. The
database used for study and analysis purposes in this research, is a version of DELPHI database
which is coded with CPCSSN standards. The database is designed to hold all medical related
information for patients in multiple tables including patients’ characteristics (i.e. gender, birth
year, postal code, etc.), demographic information, billing information, medication history, fam-
ily history, vaccine history, allergy intolerance history, physical examinations, laboratory tests
and health conditions history. The database holds the medical records of 27670 patients, from
which 5720 records have been saved with erroneous diagnostic codes including null, zero or
invalid values (codes). Diagnostic codes in the database are recorded using 9th revision of the
ICD system 2. As the purpose of this thesis is to study patients with multimorbidity, the ICD
codes have been used to identify chronic diseases, which led to the identification of patients
with multimorbidity. Further details about how the data for analysis was collected and cleaned
is described in the following section.
3.2 Data Pre-processing
In order to identify patients with multimorbidity, a list of 20 chronic disease categories (partic-
ularly relevant in clinical and general population in Canada) will be used. This list was created
by a nationally funded research project at the Canadian Institute of Health-Centered Innova-
tions, which aims to improve the quality of patient-centered interventions for patients with
multimorbidity [43]. The age, gender and postal code attributes have been extracted for all the
patients having at least one of the listed chronic conditions. The complete list of the twenty
chronic disease categories along with their corresponding ICD-9 disease codes is available in
Appendix A, Table A.1.
Detailed description of data extraction process and pre-processing of collected data can be
found in the following subsections.
2The International Classification of Diseases (ICD) is a clinical cataloging system for coding diseases. The
latest version of ICD catalogs is ICD-10, which offers more disease classification options compared to ICD-9.
ICD-9 has been used from 1979 to 2015.
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3.2.1 Data Extraction
As of the data extraction period for this research, a total of 15462 de-identified patients who
have at least one of the twenty chronic diseases listed in Table A.1, have been collected. Among
these patients, a total of 8245 have multimorbidity (the rest are diagnosed with only one chronic
disease). Patient characteristics include information on patient’s gender, masked date of birth
(year of birth without mentioning the exact day and month of birth), and masked postal code
(only first three digits of residential postal codes (a.k.a. FSA).3 4
Table 3.1 represents the counts of missing or incorrectly filled attributes for patients with
minimum of one chronic disease. The invalid instances for ‘Gender’ and ‘Birth Year’ in the
database, are the ones set to zero, and the invalid or missing values of ‘FSA’ are either not filled,
or filled with an invalid value (an FSA value is considered to be invalid if it is not included in
list of postal codes in Canada).
Attribute Name
Missing/invalid attribute counts among
patients with at least one disease
Missing/invalid attribute counts among
patients with multimorbidity
‘Gender’ 1 1
‘Birth Year’ 114 9
‘FSA’ 1645 835
Table 3.1: Missing attributes counts for patients with one or more chronic diseases.
To perform a reliable analysis, we removed the instances where the value for either one
of the attributes is missing or is invalid, and the analysis was performed based on instances
which did not have any missing attributes. Therefore, the number of patients with no missing
attributes in the database, shrank down to 13697 for patients with at least one chronic condition,
and 7395 for patients with multimorbidity.
Besides personal information attributes extracted for the patients from the main database,
a socioeconomic score was also computed from external resources for each patient in the
3The first three digits of a Canadian postal code is called Forward Sortation Area (FSA). The first character
which is a letter, identifies the province or territory (Nunavut and Northwest Territories share the letter X). For
Ontario and Quebec, the first character further identifies a particular part of the province. The second character,
which is a numeric character identifies whether the area is urban or rural. A zero indicates the area is rural, while
all other digits indicate urban areas. The third character in combination with the first and second character is a
letter which identifies a more precise geographic district [91].
4The database also includes a table for holding patients’ demographic information, such as their higher ed-
ucation level, languages, ethnicity, occupation, housing status, etc. which could potentially be used to define
socioeconomic status for patients, but unfortunately there were only a handful of non-empty instances for these
attributes, therefore, it was impractical to include them in extracted attributes.
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database. The ‘Gender’, ‘Birth Year’, ‘FSA’ and ‘Socioeconomic Score’ attributes from the
data table used for processing and analyzing. The process of how a socioeconomic score was
computed is explained in detail in the next subsection.
3.2.2 Socioeconomic Score Computation
As discussed in Chapter 2, the income level is assumed to be one of the best indicators of so-
cioeconomic status for families. Research has shown that relatively low-income families have
lower mortality rates and higher rates in health-related complications compared to relatively
high-income individuals [14]. In order to research the impact of income levels on health condi-
tion and investigate the relationship between disease patterns and income level of individuals,
a median family income was assigned to each individual in the data table. This information
was extracted from a separate data source created in 2013, where the median family income
was calculated for every FSA in Canada based on census tract-based income maps [16]. The
data source uses Google’s Fusion Tables mapping tool to map income across the country in
1576 postal areas. The results are visualized into color-coded interactive maps, each color
representing the family income level of a certain FSA. There are six colors representing six in-
come ranges, and each FSA is colored based on where the median family income for that FSA
belongs to, in income ranges. The map can be zoomed and panned to focus on a specific FSA,
and is also click-able. Once and FSA is clicked on, a message pops up showing the population
of that specific area along with its median family income value. Median income values have
been extracted from this data source, and assigned to all patients in the data table according
to individuals’ residential code. The data table was then finalized for processing by assigning
categorical labels for numeric values of ‘Birth Year’ and ‘Income by FSA’.
3.2.3 Labeling the Attributes
In order to perform efficient analysis and draw patterns out of data, two numeric attributes
‘Birth Year’ and ‘Income by FSA’ have transformed into categorical attributes.
For transforming the ‘Birth Year’ into ‘Age Group’, the stages of a person’s life have been
used as categories. To do so, the description of life stages was found in second Chapter of the
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book called It’s your future, make it a good one! [124]. As the book suggests, one’s life can
be divided up into ten stages according to Table 3.2.
Life Stage Age Range Characteristics of Life Stage
Infant 0-2 Dependent, brain developing, learning motor skills
and sensory abilities.
Child 3-9 Growing and mastering motor skills and language,
learning to play and socialize, continued growth,
formal school and organized activities
Adolescent 10-19 Growth spurts, puberty, hormonal changes and
strong emotions may rule decisions. Behavioural
risks.
Young Adult 20-29 Completing education and beginning career and
family. Potential coping and financial pressure.
Adult 30-39 Managing family and career growth. Increasing
numbers of couples are starting families in this
stage. Continued coping pressures.
Middle Age 40-60 First signs of aging and its effects on lifestyle. Ca-
reer peak. Children having their nest, grandchildren
arrive. Aging parents may require care.
Independent Elder 60 onward More signs of aging and lifestyle effects. Eligible
for government retirement and health-care benefits.
Retirement. Some health problems arise, and medi-
cations may be required. Care for others.
Vulnerable Elder 60 onward Beginning of frailty. Cognitive or multiple health
problems. Require some assistance. Not able to
drive. Possible move to Assisted Living.
Dependent Elder 60 onward Requires daily care. Unable to perform all personal
functions. Possible move to a nursing home.
End of life (up to six months) 60 onward Diagnosed with terminal condition(s) or end stage
disease(s). May require hospice care or nursing
home care.
Table 3.2: Life stages and its characteristics.
There are only two infant patients in our data table, therefore the two groups of ‘Infant’ and
‘Child’ have been merged together and labeled as ‘Child’. The four final stages of life have
also been treated the same way and labeled as ‘Elder’ in the database, as there were no further
information about the elderly on how they live or what kind of age related problems they might
be experiencing. The rest of age group categories have been labeled as they appear in the table.
With sensitivity analysis [32] we ensured that the available data for every chronic disease
in every age group is consistent. The analysis can be summarized in following steps:
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1. For every one of the six age groups G∗k,d = [i, j] (1 ≤ k ≤ 6, 1 ≤ d ≤ 20, i < j)
where k represents the age group, d represents the chronic disease code, i and j represent
the minimum and maximum ages in Gk, calculate the counts of patients diagnosed with
every one of the twenty chronic diseases.
2. Compute step 1 for the following age intervals:
G(1)k,d = [i − 1, j − 1], G(2)k,d = [i − 2, j − 2], G(3)k,d = [i + 1, j + 1], G(4)k,d = [i + 2, j + 2].
3. Compare the results of diseases counts between G∗k and every one of the intervals in step
2. If counts of patients in 0.9 × G∗k,d ≤ G(l)k,d ≤ 1.1 × G∗k,d (1 ≤ l ≤ 4) for all four age
intervals, the data for disease d and age group k is consistent.
The sensitivity analysis showed the data is consistent for all diseases among all age groups.
The numeric ‘Income by FSA’ attribute has also been labeled to form a categorical attribute.
To do so, income quintiles were used from Census Statistics Canada [17]. As the statistics
suggest, the population of individuals in Census program has been broken down into five equal
sized groups (quintiles), from lowest to highest income and the individuals’ income was labeled
based on the quintile it lies under. In our data table, there were no individuals lying under lowest
or second lowest quintiles.
Based on our considerations, the final data table after pre-processing and data cleaning
stages is as shown in Table 3.3
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Data Attribute Name Attribute Type Values Description
Hypertension Boolean {0, 1} 1 if diagnosed, else 0
Obesity Boolean {0, 1} 1 if diagnosed, else 0
Diabetes Boolean {0, 1} 1 if diagnosed, else 0
Bronchitis Boolean {0, 1} 1 if diagnosed, else 0
Hyperlipidemia Boolean {0, 1} 1 if diagnosed, else 0
Cancer Boolean {0, 1} 1 if diagnosed, else 0
Cardiovascular Disease Boolean {0, 1} 1 if diagnosed, else 0
Heart Failure Boolean {0, 1} 1 if diagnosed, else 0
Depression Boolean {0, 1} 1 if diagnosed, else 0
Arthritis Boolean {0, 1} 1 if diagnosed, else 0
Stroke Boolean {0, 1} 1 if diagnosed, else 0
Thyroid Boolean {0, 1} 1 if diagnosed, else 0
Kidney Disease Boolean {0, 1} 1 if diagnosed, else 0
Osteoporosis Boolean {0, 1} 1 if diagnosed, else 0
Dementia Boolean {0, 1} 1 if diagnosed, else 0
Musculoskeletal Problem Boolean {0, 1} 1 if diagnosed, else 0
Stomach Problem Boolean {0, 1} 1 if diagnosed, else 0
Colon Problem Boolean {0, 1} 1 if diagnosed, else 0
Liver Disease Boolean {0, 1} 1 if diagnosed, else 0
Urinary Problem Boolean {0, 1} 1 if diagnosed, else 0
Gender Categorical {Male, Female}
Age Group Ordinal {1, 2, 3, 4, 5, 6} 1: Child 0-9 years
2: Adolescent 10-19 years
3: Young Adult 20-29 years
4: Adult 30-39 years
5: Middle Age 40-60 years
6: Elder 60 onward
Socioeconomic Score Categorical {3, 4, 5} 3: Third income quintile
4: Fourth income quintile
5: Higest income quintile
Table 3.3: The structure of final data table used for processing, analyzing and clustering
Chapter 4
Data Analysis
This chapter presents different approaches taken to analyze the patient data with the aim of
finding similarities in demographic characteristics among patients with multimorbidity and
specifically those with the same combination of diseases.1 As it is shown in Table 4.1, the
total number of patients with multimorbidity decreases as the number of coexisting diseases
grows, and every group of patients with the same number of diseases breaks down into even
smaller groups for each combination of diseases. Therefore, the available data for analysis of
subgroups of patients with same combination of diseases is scarce for more than two coexisting
diseases. Due to this reason, the main cluster analysis in this research has been performed only
on data of most commonly occurring disease combinations among patients with two chronic
diseases.
All statistical and mathematical analysis approaches taken to analyze this data set are di-
vided into three main parts and explained in following three sections. Section 4.1 explains the
overall analysis of the database, it represents patient distribution over gender, age groups and
socioeconomic score without focusing on number of coexisting diseases. Sections 4.2 and 4.3
represent the analysis performed on a subgroup of patients diagnosed with two chronic dis-
eases: Section 4.2 includes the different statistical approaches taken to analyze data for two
coexisting diseases, while Section 4.3 provides detailed description of the clustering approach
for clustering demographic information of patients with specific combinations of two chronic
1According to Table 3.3 the available patient demographics in this research is gender, age group and socioe-
conomic score.
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diseases. Finally, Section 4.4 includes the analytical results of patients diagnosed with three
chronic diseases.
4.1 Disease Frequencies and Distributions
This section provides detailed analysis about the prevalence of diseases among patients. Dis-
ease counts and distributions have been computed for all age groups and socioeconomic scores
separately and the results are represented in form of charts, tables, graphs and other statistical
measurements.
Table 4.1 and Figure 4.1 show that the average number of coexisting diseases grows with
age. This evidence shows that prevalence of multimorbidity increases by age. According to
the Table 4.1, elder and middle aged groups are the most dominant age groups in this dataset in
terms of frequencies, forming 46.4 and 36.1 percent of patients respectively. The distribution
of male and female patients is 44.77 and 55.23 percent respectively, and regardless of number
of coexisting diseases, the counts for female patients is always greater than male patients.
However, this does not imply that females are generally sicker than males, because the limited
sources of data forming the DELPHI database. As it is shown in Figure 4.1 the average number
of diseases per patient among males and females is 2.15 and 2.19 respectively, with standard
deviations of 1.46 and 1.52, respectively.
Figure 4.1: Average number of diseases
Table 4.1 also provides information regarding to percentage of patients according to the
number of diseases they are diagnosed with. As shown in the table, the total counts of patients
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decreases exponentially as the number of coexisting diseases grows. This makes the analy-
sis of patient data with larger numbers of coexisting diseases more challenging or sometimes
impossible due to lack of data. Because of this, the main focus in this research is on statisti-
cal analysis and clustering of patients with two coexisting diseases. However, some statistical
analyses have been done on patients diagnosed with one, two or three diseases.
As presented in Figure 4.2, increasing age can be associated with increasing prevalence
of some chronic diseases. Some conditions tend to appear more with increases in age (e.g.
hypertension, diabetes, hyperlipidemia, cancer, cardiovascular disease, hearth failure, arthritis,
osteoporosis and dementia) [104], while other conditions tend to occur less with growth of age
(such as bronchitis and obesity), and some other conditions tend to appear more among certain
groups and less in other age groups (an example is depression which occurs the most among
young adults and adults, and decreases in older individuals). Hypertension and hyperlipidemia
are the two most commonly occurring diseases, appearing 46% and 34.5% of the elderly, re-
spectively. Liver disease is the least occurring disease among all age groups and, at its peak,
appears 0.4% of middle aged group. There are two charts included in Appendix A illustrating
the disease distributions over all age groups in more detail: Figure A.1 represents the absolute
counts of diseases for every age group in a greater detail, and Figure A.2 represents disease
percentages for all age groups for males and females separately.
Patient distribution and their basic characteristics have also been analyzed for the three
socioeconomic scores separately: The majority (73.66%) of patients in this data set belong to
fourth income quintile, almost about 25.57% of the patients belong to highest income quintile
and the rest belong to third income quintile.2 As shown in Figure 4.1, the average number of
diseases for patients with moderate income level equals 3.14 with a standard deviation of 1.82,
which is greater when compared to the other two groups. This can imply that patients with
relatively lower income levels are more likely to be diagnosed with multiple diseases when
compared to individuals with higher income levels. However, exploring this hypothesis is not
in the scope of this research.
Figure 4.3 is shows the percentages of patients diagnosed with each of the twenty chronic
2Third, fourth and highest income quintiles represent families with moderate, high and highest income levels,
respectively.
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Figure 4.3: Disease percentages for the three income quintiles of individual diseases.
diseases for each income quintile. If the diagnosis of chronic diseases was not associated with
socioeconomic status, the heights of the three bars for every disease were expected to be in
the same range. As shown in the figure, bar heights are in the same range only for some
of the diseases. Some diseases are shown to appear more frequently among individuals with
moderate income level (examples in this data are bronchitis, cardiovascular disease, depression
and musculoskeletal problems). However, caution must be used in drawing any conclusions
about the relationship between socioeconomic status and the prevalence of diseases mentioned
above for two reasons: (1) the factors included for measuring socioeconomic status are limited
to the area the patient lives in and an estimation of their income level, as well as the lack
of many other important parameters such as race, ethnicity, level of education, occupation,
smoking and drinking habits, etc. (2) available instances for every socioeconomic group are
not of equal (or almost equal) size (there are only 105 individuals from third quintile of income
in this database).
However, there has been other research which has specifically focused on the impact of
socioeconomic status on diagnosis, prognosis, and prevalence of a certain chronic disease. For
example Alexis Ferré et al.have researched and confirmed that socioeconomic status influences
both the prevalence (higher in low categories) and rate of diagnosis (lower in high categories) of
bronchitis [41]. Similarly, Alexander M. Clark and colleagues have researched the relationship
between socioeconomic status and cardiovascular disease by associating lower socioeconomic
status to higher prevalence of cardiovascular disease [21]. Other related research analyzed the
influence of socioeconomic status on depression, obesity and diabetes [36], which suggests
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poor socioeconomic status affects physical and mental health and functioning of young adults
and the effects persist across the life time. Some evidence of this is also illustrated in Figure
4.3.
On the other hand, there is research showing no socioeconomic differences is evident for
prevalence of some chronic conditions such as cancer, kidney disease and skin disease [29]. A
detailed survey analyzing the racial and ethnic influences on health can be found in [26].
In this section, we have analyzed the prevalence of chronic diseases individually among
patients belonging to different age groups, gender categories and socioeconomic status, without
concentrating on coexisting diseases in patients. The following section provides similar data
analysis for individuals with two coexisting diseases.
4.2 Analysis of Two Coexisting Chronic Diseases
In order to analyze prevalence of multimorbidity, combinations between two diseases have
been analyzed with statistical measurement methods introduced in Chapter 2 subsections 2.1.1
and 2.1.2.
4.2.1 Total Counts and Pairwise Association of Two Chronic Diseases
As it was discussed in Chapter 2, disease counts is the most preliminary way to determine the
prevalence of multimorbidity. According to Table 4.1, 43.06% of patients with multimorbidity
are diagnosed with two chronic conditions, 87.53% of which are elder or middle aged.
Figure 4.4 shows the total counts of diseases as they appear among patients with two
chronic conditions. Each circle in the plot represents the existence of corresponding disease
combinations. The diameter of each circle refers to the relative percentage of patients diag-
nosed with the corresponding disease combination. As shown in Figure 4.4, hypertension is
the most commonly occurring disease among patients with multimorbidity: It appears among
31.17% of patients diagnosed with two conditions, and 47.96% of patients with multimorbid-
ity. Hypertension and hyperlipidemia is the most occurring disease combination which affects
225 patients in the database. Musculoskeletal problems is the other relatively dominant disease
commonly co-occurring with other conditions.
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Figure 4.4: Disease combination counts for two coexisting diseases. Each circle on the plot
represents the relative percentage of instances in the dataset who have the two chronic condi-
tions as named on x and y coordinates.
Disease associations have also been measured according to pairwise association measure-
ment methods introduced in Chapter 23. Odds ratios, multimorbidity coefficients, and Kappa
statistics 4 suggest the highest rate of pairwise association refers to heart failure and kidney
disease. According to odds ratios (ORHeartFailure,KidneyDisease = 10.927), the chance of having
kidney disease if one has heart failure is 10.927, and with 95% confidence the true odds ratio
lies in the rage of 6.97 and 17.11. Similarly, Kidney disease and hypertension, cardiovascular
disease and heart failure, are defined as other highly associated disease pairs. A complete list
3In order to avoid the inaccuracy of results due to selection bias, all patient records available in DELPHI
database have been included in measuring pairwise association between diseases; this also includes patients who
are not diagnosed with any chronic conditions.
4Computed using equations 2.1, 2.3, 2.4.
4.2. Analysis of Two Coexisting Chronic Diseases 53
of odds ratios for all disease pairs is available in Appendix A, Table A.2, and the corresponding
95% confidence intervals are presented in Table A.3. Multimorbidity coefficients of all pair-
wise disease combinations is also included in Appendix A, Table A.4: greater multimorbidity
coefficients refer to higher pairwise association levels. Some of the highly associated pairs
have also appeared commonly in disease pair counts (Figure 4.4), such as hypertension and
hyperlipidemia, hypertension and diabetes.
4.2.2 Disease Combinations Based on Gender
The distribution of male and female patients with two chronic conditions is 44.96% and 55.04%,
respectively. Table 4.2 shows percentages of patients who have two chronic diseases in every
age group based on gender. As the distributions suggest, multimorbidity in younger age groups,
according to the data in the DELPHI database, appears to be slightly more prevalent among
females compared to males.
Child Adolescent Young Adult Adult Middle Age Elder Total
Male (%) 0.42 1.12 2.87 6.43 36.55 52.62 44.96
Female (%) 0.17 1.54 4.91 7.19 38.18 48 55.04
Table 4.2: Percentages of patients for all age groups based on gender
According to Figures A.3 and A.4 in Appendix A, the disease pair hypertension and hy-
perlipidemia is most commonly appearing among both males and females. However, some
diseases might be more gender specific. For instance, hypertension and hyperlipidemia tend to
co-occur with a second disease more often among males than females, while depression, thy-
roid problems and osteoporosis are the three diseases which co-occurs with a second disease
relatively more often among females compared to males.
4.2.3 Disease Combinations Based on Age Groups
As mentioned earlier in Section 4.1, the prevalence of some chronic conditions increase in
older population. Therefore, it is expected that multimorbidity is also occurring with a higher
prevalence and more variety among older age groups. We have analyzed the validity of this
hypothesis by performing statistical analysis on patients with multimorbidity among all age
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groups. As shown in Table 4.3, the prevalence of having two chronic conditions grows by age,
such that it is extremely rare among children, and mainly appears among middle age and elder
groups. The table provides the percentage of patients with two chronic conditions among all
age groups.
Child Adolescent Young Adult Adult Middle Age Elder
2 coexisting diseases (%) 0.28 1.35 3.90 6.75 37.17 50.02
Table 4.3: Patient distribution percentages among all age groups for patients with two chronic
conditions.
The variation of disease combinations also grows by age. Almost all possible combinations
of two chronic conditions can be found among elderly. The distribution of disease combina-
tions among every age group is presented in six figures in Appendix A (Figures A.5 to A.10).
Based on the results in these Figures, disease combinations appear with three main trends: (1)
The occurrence between some disease pairs is more dominant among younger age groups and
decreases among older age group. For instance, the occurrence of bronchitis and other diseases
is dominant among younger age groups and diminishes among older age groups. (2) Some dis-
ease pairs tend to appear more with growth of age, including hypertension and other diseases,
which start to appear from age group 3 (young adults) and grows with age and becomes the
most dominant disease among elderly. (3) Some disease combinations seem to be age specific,
which means they seem to peak among certain age groups. An example is the combination be-
tween depression and other diseases: this first appears among adolescents, increases in young
adults, and starts to decrease in later stages of life, such that among elders the combination of
depression with another chronic condition is relatively rare.
4.2.4 Disease Combinations based on Socioeconomic Scores
As Table 4.4 suggests, patients with two chronic conditions mainly belong to families in high
income quintile and form 74.96% percent of the population of patients with two chronic con-
ditions.
The distribution of the prevalence of disease pairs belonging to each one of the socioeco-
nomic groups is illustrated in Figures A.11, A.12 and A.13 in Appendix A. As shown in those
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Child Adolescent YoungAdult Adult MiddleAge Elder Total
Moderate Income 0 0 3 3 9 2 17
High Income 6 35 86 159 920 1180 2386
Highest Income 3 8 38 56 263 412 780
Table 4.4: Patient counts for each age group based on family income quintiles. Only patients
with two chronic condition are listed in this table.
Figures, the distributions of disease pairs among patients belonging to the moderate family in-
come quintile is very different from those belonging to high or highest family income quintiles,
while the high and highest income quintiles suggest a similar distribution among disease pairs.
However, these results do not imply that disease combinations have a different pattern among
patients with two chronic conditions who belong to moderate family income level, compared
to those belonging to high or highest family income levels. The reason for different disease
patterns might be related to insufficient population of patients belonging to the moderate fam-
ily income level in this database. Disease pair combinations among two subgroups of patients
from high and highest income levels are very similar to the combinations for all patients with
two chronic conditions (Figure 4.4). This observation suggests that belonging to different in-
come levels does not necessarily imply a visible change in multimorbidity patterns for patients
with two chronic conditions.
In analyzing disease pair combinations for gender and age groups we were able to see some
patterns which may suggest the presence of clusters. For socioeconomic scores, it is harder to
see whether it is a parameter upon which disease pair combinations can be clustered.5 In the
next section we introduce a clustering algorithm for clustering characteristics of patients diag-
nosed with the same two chronic conditions and explore the presence or absence of possible
clusters.
5It is important to note that there are major assumptions made for calculating the socioeconomic score in
this research, and the socioeconomic score basically takes into account patients FSA and their potential family
income level. Therefore, the results implied from disease combinations among patients belonging to different
socioeconomic levels will possibly not be applicable for the national population of Canada.
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4.3 Clustering of Data for Two Coexisting Diseases
This section is devoted to introducing the clustering algorithm used for clustering most com-
monly appearing disease pairs, as well as associated experimental results. The algorithm used
for this purpose is a variation of k−modes adjusted to fit with the data table used in this re-
search. In this regard, k−modes algorithm is explained in detail; it is compared with the
original k−means in terms of similarities and differences. Following the introduction of the
algorithm and its adjustments, the experimental results are presented in the final sub-section of
this section.
4.3.1 K-means vs. K-modes
As mentioned in section 2.1.3, one of the limitations of the k−means algorithm is its distance
based computational nature, which allows the algorithm to fit only for numerical data sets. To
overcome this limitation, researchers have suggested different approaches6, one of which is the
k−modes algorithm. This approach is a variation of the k−means algorithm used for clustering
data containing only categorical data types by making three main modifications to k−means:
(1) using a simple matching dissimilarity measurement method for categorical data types, (2)
computing modes instead of mean to define cluster centers, and (3) using a frequency-based
method to update centers of clusters.7 The following paragraphs represent the notations and
description of the k−modes algorithm in detail.
Assume that D is a set of n elements noted as D = {X1, ..., Xn}, where each element is
represented by a set of m attributes noted as A1, ..., Am, and each attribute contains a set of
values described as domain of values or Dom(Ai) for 1 ≤ i ≤ m. As noted earlier, the k−modes
6One of these approaches was presented by Ralambondrainy in 1995 [96], where categorical attributes were
converted into binary attributes by using 0 or 1 to show whether the category is absent or present, and the binary
values were treated as numeric attributes in the same k−means algorithm. In this approach, every categorical
attribute with m possible categories(values), will need to be divided into m binary attributes, each indicating
whether or not the value i for 1 ≤ i ≤ m is present. Therefore, it must handle a very large set of attributes for
databases where there are large sets of categorical attributes, because every value of each categorical attribute
will need to become an independent binary attribute. Due to this, the computational and space complexity of the
algorithm can inevitably increase in some cases. Also, clusters means lose their meaning as characteristics of
clusters in this approach because of the presence of binary values which will be real numbers 0.0 and 1.0.
7To discuss the clustering algorithms in this chapter, an assumption has been made that all data types can be
converted into either numerical or categorical data types.
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algorithm is valid for clustering data-sets containing categorical data types only. Therefore, in
this notation Dom(Ai) is a finite and unordered set. An instance in data-set D is represented by
X j for 1 ≤ j ≤ n, which is an m−dimensional data vector represented as X j = [x j,1, x j,2, ..., x j,m]
where x j,i ∈ Ai, and all attributes of X j are of type categorical. In this notation, it is assumed
that all data instances have exactly m attributes, all attributes are categorical, and there are no
missing values. Consequently, Xi = X j if xi,k = x j,k for 1 ≤ k ≤ m and 1 ≤ i, j ≤ n. However
the equation Xi = X j does not imply that the two instances Xi and X j are pointing to the same
object in real word, it means that the two separate instances have equal values for all attributes
A1, ..., Am [58].8
The main steps of the k−modes algorithm are same as the k−means. Although, the follow-
ing modifications have been made to k−means to make it computable for categorical attributes.
Here are the main computational changes for clustering a categorical data-set using k−modes:
Data points’ dissimilarity measure: In k−means the Euclidean distance is used to define
the dissimilarity between two data points, while it is not generally applicable to categorical data
types. Therefore, in k−modes, the dissimilarity measure is the total number of mismatches of
all attributes for two instances. In other words, the dissimilarities between two data points X
and Y is the Hamming distance of the two instances, which is calculated as follows:
η(X,Y) =
m∑
j=1
δ(x j, y j) (4.1)
where
δ(x j, y j) =
{
0 (x j = y j)
1 (x j , y j)
(4.2)
Using modes instead of means: As noted in definition of k−means, after assignment of all
data points to cluster groups based on the distance measure, all clusters’ centroids are updated
8In our database, Xi = X j if gender, age group and socioeconomic score are equal in two patients who have
the same diseases.
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by computing the mean vector for every one of the clusters. Due to the nature of categorical
attributes, computing means is not useful for this attribute type. Therefore, a different but
similar measure has been used in k−modes - to find and place a data point in a cluster (e.g. q)
in a way that minimizes the overall Hamming distance between all data points and q. Assuming
that S is a set of n categorical instances defined as S = {s1, s2, ...sn}, a mode of S is a vector
q = {q1, q2, ..., qm} that minimizes the sum of hamming distances between all instances of S
and q. In other words, q is the mode of S if it minimizes the following equation:
d(S , q) =
n∑
i=1
η(si, q) (4.3)
According to the following theorem, the computational metric to minimize equation 4.3 is
proven to be mode of the cluster. The proof of the theorem can be found in Appendix A.
Theorem1. The function d(S,q) is minimised if and only if fr(A j = q j|S ) ≥ fr(A j = ck, j|S ) for
q j , ck, j for all j = 1, ...,m, where fr(A j = ck, j|S ) =
nck, j
n
stands for the relative frequency of
k−th category ck, j in attribute A j from set S .
From Theorem 1 it is implied that the mode of a set S is not unique, and it is not necessarily
an element of S .
Using frequency-based methods for updating centers of clusters: Cluster representa-
tives in both the k−means and k−modes algorithms are vectors containing the same attributes
as all data points in data set. The cluster representative vector may or may not be one of the
data points in data set, and they are used to compute the distance between the data points and
clusters in order to assign every data point to the nearest cluster. In contrast to the k−means
algorithm where cluster representatives are mean vectors for every cluster (also called cen-
troids), in the k−modes algorithm the mode vector is the cluster representative, and it is created
by calculation of modes for all attributes in every cluster.
K−modes algorithm steps: By introducing the main differences between k−means and
k−modes, the main steps of the latter algorithm are provided below:
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1. Initialization: Select k initial modes, one for representing each cluster
2. Data point assignments: Every one of the data points will be allocated to a cluster whose
mode is nearest to it based on equation 4.1. Update the mode for the cluster every time a
new instance is assigned to it.
3. Reassigning instances: Once all data points have been allocated to clusters, retest the
Hamming distances between every data point in all the clusters. If a data point is nearer to
a different cluster mode according to equation 4.1, reallocate the instance to that cluster,
then update the mode for both clusters.
4. Repeat step 3 until the number of data points moving between clusters is zero.
Similar to the k−means algorithm, the results of the k−modes algorithm are dependent on
the initial modes and the order of objects in the dataset [58]. There are two main methods for
selecting initial modes: (1) Randomly selecting k instances from the data set and use them as k
modes. (2) Distribute most frequently occurring categories of attributes equally among initial
modes. The second method needs more processing power, and is explained in full detail in
subsection 4.3.2
One of the limitations of k−modes algorithm is its applicability on data containing only
categorical data types. In order to overcome this limitation, a more generalized algorithm
named k−prototypes has been introduced by Huang in 1997 [57], which integrates k−means
and k−modes to allow data clustering for databases containing mixed numerical and categorical
attributes.9 Detailed description of the algorithm can be found in [57].
The attribute types of all features in the data table used in this research are categorical.
Therefore, the k−modes algorithm is well suited to be used for clustering the data. The al-
gorithm has been adjusted for the database and implemented in order to find clusters among
patients sharing the same diseases.
9The clustering process of the k−prototypes algorithm is similar to k−means, except that it uses the k−modes
algorithm approach to update the categorical attribute values in centroids. Assuming sr is dissimilarity measure
for numeric attributes (which was defined by Euclidean distance in k−means) and sc is dissimilarity measure for
categorical attributes, defined by counting the matches and mismatches of categorical attributes, the dissimilarity
measure for two data instances having mixed categorical and numeric values in the k−prototypes algorithm will
be sr + γsc, where γ is a coefficient (weight) to balance the effect of either type of attribute when computing
distance between two data points.
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4.3.2 K-modes Adjustments and Implementation
In this research the k−modes algorithm has been implemented for finding clusters among pa-
tients who share same pair of diseases. However, an adjustment has been made to distance
measurement method of the algorithm, in order to make the clustering results more reliable.
This sub-section explains the alternative measurement method and the implementation of the
algorithm in full detail.
Alternative distance measurement method: The socio-demographic attributes of data
points in our data are the following:
Gender = {Male, Female}
AgeGroup = {Child, Adolescent,YoungAdult, Adult,MiddleAge, Elder}
S ocioeconomicS core = {Moderate,High,Highest}
Even though these attributes are categorical, the categories of the latter two attributes can
be ordered from lowest/youngest to highest/oldest. Using Hamming distance to calculate the
distance between two data points in this case, will show dissimilarities to some extent, but it
will fail to recognize the level of dissimilarity in many cases. For instance, assume that there
are three patients with following attributes:
p1 = [Male,Child,Highest] p2 = [Male, Elder,Moderate] p3 = [Female,Child,High]
According to distance measure in k−modes (i.e. equation 4.1), the distance between the two
pairs (p1, p2) and (p1, p3) will be η(p1, p2) = η(p1, p3) = 2, while the pair (p1, p3) appears to be
sharing more similar socio-demographic information compared to pair (p1, p2). Dissimilarity
of data points can be measured more accurately by using the Manhattan distance10[74].
Manhattan distance: For two m−dimensional vectors X = [x1, ..., xm] and Y = [y1, ..., ym],
the Manhattan distance is defined as the sum of absolute differences for every attribute in these
vectors. More formally,
dµ(X,Y) =
m∑
j=1
|x j − y j| (4.4)
10The Manhattan distance is also known as rectilinear distance, L1 distance, snake distance or city block dis-
tance.
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More specifically, if we associate the three attributes Gender, AgeGroup, Socioeconomic-
Score as attribute 1, 2 and 3 respectively, the Manhattan distance of two patients pi and p j in
our database can be defined as following:
dµ(pi, p j) = |pi,1 − p j,1| + |pi,2 − p j,2| + |pi,3, p j,3| (4.5)
Methods for generating k initial mode vectors11: The k−modes algorithm can be ini-
tialized either by randomly selecting and associating k data points as initial cluster centers, or
by generating initial k modes by distributing most frequently occurring categories for each at-
tribute. In random selection of k initial mode vectors, k data points are randomly selected from
the main data set and placed as initial cluster representatives. However, the second approach
for generating initial mode vectors requires more programming effort, and there is more than a
unique method for implementing it. The strategy applied in this research for generating initial
mode vectors is explained in the following steps:
1. Calculating frequencies: The frequencies of all categories for all attributes are calculated
and stored in a category array.
2. Sorting frequencies: The frequencies for every attribute is sorted in descending order
such that f (ci, j) ≥ f (ci+1, j) where f (ci, j) is the frequency of category i for attribute j.
There is an example of a category array holding categories of m (in this case 5) attributes
in equation 4.6. For every attribute a j where 1 ≤ j ≤ m, n(a j) represents the number of
categories of a j. For instance, in this example n(a2) = 5.
11A mode vector for cluster C is a data vector v = {v1, v2, ..., vm}where vi ∈ Dom(ai) represents the one category
in attribute ai with most occurrences among all data points of cluster C.
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Carray =

c1,1 c1,2 c1,3 c1,4 c1,5
c2,1 c2,2 c2,3 c2,4 c2,5
c3,2 c3,3 c3,4 c3,5
c4,2 c4,4 c4,5
c5,2 c5,4
c6,4

(4.6)
Column j for 1 ≤ j ≤ 5 in equation 4.6 represents the frequencies of all categories of
attribute j in descending order, and ci, j stands for category i of attribute j.
3. Shifting the category array: In order to distribute most frequently occurring categories
equally among the k initial modes (in this example k = 3), every attribute needs to be
shifted circularly in a vertical manner in the category array such that x−th attribute will
have x− 1 vertical shifts from bottom to top. With every shift, the category positioned as
the last item of the column, will become the first item, and all the other items (categories),
will shift down one row. According to the descriptions, the category array in equation
4.6 will become as in equation 4.7 after all shifts :
Carray =

c1,1 c5,2 c2,3 c4,4 c1,5
c2,1 c1,2 c3,3 c5,4 c2,5
c2,2 c1,3 c6,4 c3,5
c3,2 c1,4 c4,5
c4,2 c2,4
c3,4

(4.7)
As shown in equation 4.7, there are no shifts for a1, 1 shift for a2, 2 shifts for a3, 3 shifts
for a4 and 4 shifts for a5.
4. Initializing k modes: After shifting the elements of attribute array, the empty spots of
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the array will be filled with categories in the same order, for each attribute. For instance,
as attribute a1 has two categories, it has four less categories compared to a4 which con-
tains the maximum number of categories. Therefore, empty spots in first column (i.e.
in attribute 1) in 4.7 will be filled with categories of a1 with the same order as they ap-
peared after shifting the array. The category array after filling the empty spots will be as
following:
Carray =

c1,1 c5,2 c2,3 c4,4 c1,5
c2,1 c1,2 c3,3 c5,4 c2,5
c1,1 c2,2 c1,3 c6,4 c3,5
c2,1 c3,2 c2,3 c1,4 c4,5
c1,1 c4,2 c3,3 c2,4 c1,5
c2,1 c5,2 c1,3 c3,4 c2,5

(4.8)
Initial modes can be created once the array is filled. In this example every row of cat-
egory array in 4.8 represents one initial mode, where the categories have been equally
distributed among modes. For k = 3, the initial modes according to 4.8 will be:
q1 = [c1,1, c5,2, c2,3, c4,4, c1,5]
q2 = [c2,1, c1,2, c3,3, c5,4, c2,5]
q3 = [c1,1, c2,2, c1,3, c6,4, c3,5]
In order to avoid repetitive modes for k > n(amax) where amax stands for the maximum
number of categories among all attributes (in this case n(amax) = n(a4)), repeat step 3
after every n(amax) generations of modes. For instance, if k = 14 and n(amax = 6), step
3 is required to be repeated twice: once after generating 6th initial mode, and once after
generating 12th initial mode.
Modified k−modes Algorithm: After introducing the modification to distance measurement
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method of the k−modes algorithm, here we provide the complete pseudocode of the algorithm
which is adjusted for creating clusters of patients diagnosed with same pair of chronic diseases
in our data table. The purpose of this algorithm is to find clusters over age group, gender and
socioeconomic score of the patients who are diagnosed with same two diseases, and analyze
whether or not they are also sharing the same or similar demographics. The name (or code) of
the two chronic diseases is passed to the algorithm as input parameters, and the initialization
step, extracts all patients diagnosed with the same two diseases are from the data table and
stored in a temporary memory for further analysis.12
The following subsection, provides the experimental results for clustering of commonly
occurring disease pairs.
4.3.3 Experimental Results
The number of possible combinations for two diseases to co-occur from a list of 20 diseases
equals to 20 × 19 = 380. However all of these combinations do not occur among patients in
DELPHI database: there are certain combinations of diseases which occur more frequently.
In order to perform further research and find the similarities in characteristics of patients
with same combination of diseases, a list of most frequently occurring combinations of multi-
ple chronic diseases was collected from a different research [90], where disease combination
counts have been derived from the CPCSSN database which is a relatively greater data source
compared to the one used in this research. Having access to information derived from a greater
population size ensures the reliability of results to some extent. This list contains most fre-
quently occurring disease combinations for two coexisting diseases. These combinations are
used for further analysis and clustering of patients in our dataset. Table 4.5 shows the common
combinations of diseases for two coexisting conditions according to CPCSSN database.
The individuals with same pair of chronic conditions have been clustered according to the
modified version of the k−modes algorithm (Algorithm 1). The metric for determining the
number of clusters for each pair of disease is minimization of within-cluster sum of squared
12It is important to note that for extracting patients with two chronic disease d1 and d2, the patients with only
two diseases are considered for searching in the main data table. In other words if a patient is diagnosed with
three diseases d1,d2 and d3, they will not be included in the list of patients diagnosed with d1 and d2.
4.3. Clustering of Data for Two Coexisting Diseases 65
Algorithm 1 Modified k−modes algorithm for clustering demographic information of patients
diagnosed with most commonly occurring pairs of chronic diseases: Part 1
1: procedure Modified-k-modes(k,Dss1,Dss2,DataS et, InitializeMethod)
// k : number of clusters
// Dss1 and Dss2 : the two diseases existing among all patients in DataS et
// DataS et : The data array holding the records of patients having Dss1 and Dss2.
// Deciding which method to use for initializing the centroids (initial mode vectors)
2: if InitializeMethod == “Random” then
3: centroids← Select K random patients’ from DataS et
4: else // Generate K initial modes
5: centroids←GenerateCentroids(k,DataS et)
6: end if
// Continue data point assignments until no data points move between clusters
7: repeat
// assign data points to clusters
8: for every data point pi in DataS et do
9: Compute Manhattan distance of pi with all centroids
10: find j such that dµ(pi, centroids( j)) is minimized
11: cluster(pi)← j
12: centroids( j)←UpdateCluster( j,DataS et)
13: end for
// Checking for any potential data points that can be switched between clusters
14: for every cluster j do
15: if pi in cluster j exists such that dµ(pi, centroids(x)) < dµ(pi, centroids( j)) then
16: cluster(pi)← x
17: centroids( j)←UpdateCluster( j,DataS et)
18: centroids(x)←UpdateCluster(x,DataS et)
19: end if
20: end for
21: until no data points in DataS et switch between clusters (i.e. convergence)
22: end procedure
errors (computed according to equation 2.8). Both methods of centroid initialization (random
selection and creation of centroids based on attribute modes) were tested on all commonly
occurring disease pairs: Number of clusters and their distribution was not affected by the ini-
tialization method for all disease pairs. Therefore, the results presented in this section stand for
both initialization methods.
Figure 4.5 represents clusters appeared for individuals diagnosed with hypertension and
hyperlipidemia. In the DELPHI database this disease pair appears most frequently among
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Algorithm 2 Modified k−modes algorithm: Part 2
23: function GenerateCentroids(k,DataS et)
24: Calculate and sort the frequency of each category for every attribute
25: [g1, g2]← frequencies of Male and Female categories in gender attribute
26: [a1, a2, a3, a4, a5, a6]← frequencies of age group categories
27: [s1, s2, s3]← frequencies of socioeconomic score categories
28: Carray ←Sort each column of Carray based on frequency in decreasing order
29: Carray ←Apply 1 and 2 circular shifts to column 2 and 3 in Carray respectively
30: for i = 1 : k do // Generate i− centroid and store in i − th row of centroids
31: if mod(i, 6) == 0 then
32: Carray ←Apply 1 and 2 circular shifts to column 2 and 3 in Carray respectively
33: end if
34: centroids(i)← Carray[i, :]
35: end for
36: return centroids
37: end function
38: function UpdateCluster( j,DataS et) // update mode vector of cluster j
39: Count frequency of every category in all attributes of data points which belong to
cluster j
40: [g1, g2]← frequencies of Male and Female categories in gender attribute
41: [a1, a2, a3, a4, a5, a6]← frequencies of age group categories
42: [s1, s2, s3]← frequencies of socioeconomic score categories
43: g∗ ← max(g1, g2), a∗ ← max(a1, a2, a3, a4, a5, a6), s∗ ← max(s1, s2, s3)
44: centroids( j)← [g∗, a∗, s∗]
45: return centroids( j)
46: end function
patients diagnosed with two chronic illnesses. As the figure suggests, the two dimensions of
the plot represent socioeconomic score and age group of individuals. Clusters are distinguished
with different colors: the lighter luminance of a color represents the male individuals, and the
darker luminance stands for the female individuals in a cluster. Each pie on every block of the
graph represents the cluster appeared for corresponding socioeconomic score and age group.
The radius of every pie shows the relative number of instances (patients) belonging to that
cluster. Every pie is partitioned into two slices, showing the proportion of male and female
patients in the cluster. Two clusters overlap if they appear in the same block and correspond
to the same gender attribute. For instance, in Figure 4.5 clusters 2 and 3 would overlap if
they both belonged to whether male or female patients. The legend of the graph shows every
cluster’s corresponding colors for both male and female patients. For each cluster, one of the
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Diseases Combination Patient Counts in DELPHI
1 Depression and Musculoskeletal Problem 49
2 Hypertension and Musculoskeletal Problem 50
3 Hypertension and Hyperlipidemia 225
4 Hypertension and Diabetes 132
5 Cancer and Musculoskeletal Problem 37
6 Cancer and Depression 20
7 Hypertension and Depression 30
8 Hypertension and Cancer 58
9 Hyperlipidemia and Musculoskeletal Problem 36
10 Bronchitis and Musculoskeletal Problem 82
Table 4.5: 10 most frequently occurring disease combinations derived from CPCSSN
database [90]. Disease combinations are sorted by frequency of occurrence among patients
in CPCSSN database. The column Patient Counts in DELPHI represents the number of indi-
viduals with corresponding diseases combination in DELPHI database which was used for this
research.
squares in the legend is marked with a cross: this refers to the gender attribute of the centroid of
corresponding cluster. For instance, in Figure 4.5, the gender attribute of centroids for clusters
1 and 3 is male and for cluster 2 is female. Finally, the pie on the right side of the plot represents
patients distributions for every cluster. The distribution of weights on all attributes is equal for
measuring the distance between two data points.
As the clustering results for hypertension and hyperlipidemia suggest, partitioning the data
over three clusters minimizes within-cluster sum of squared errors. The clusters do not have
any overlap and they partition the data over gender and age group. According to Figure 4.5,
the population of the elder age group with hypertension and hyperlipidemia is almost twice as
much as middle aged group: therefore the clusters split the data over the two main age groups
(middle age and elder) and then divide males and females in elder age group.
Table 4.6 summarizes the distribution of patients diagnosed with one of the commonly oc-
curring chronic disease pairs over all age group and socioeconomic categories. As the table
suggests, there are two common disease pairs widely spread among almost all age group (ex-
cluding child age group) and all socioeconomic groups. The rest of the disease pairs mainly
occur among older age groups and socioeconomic scores 4 and 5. Musculoskeletal problem
and hypertension appear among 5 of this disease pair as one of the two diseases.
Clustering results for the other nine commonly occurring disease pairs (listed in Table 4.5)
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Figure 4.5: Clusters of patients with hypertension and hyperlipidemia. Each pie with color c
on block [x, y] represents the patients with socioeconomic score x, age group y who belong to
cluster c. The radius of the pie represents the relative number of patients existing in correspond-
ing block in graph. Color shade represents gender. As the clusters suggest, patients belonging
to the fourth and fifth age group have been divided from patients of age group 6. Cluster 1
belongs to male and female patients from age group four and five. The other two clusters be-
long to elder patients and each one holds patients of one gender attribute. The clusters for this
disease pair do not separate the patients over their socioeconomic score.
are included in Appendix B Figures B.1 to B.9. According to this results, the number of
clusters dividing patients in each disease pair is ranging between 3 and 5. For all ten disease
pairs, some of the clustered are divided based on gender and most of them are also divided
based on age group. Patients partitioning over socioeconomic score has also happened among
4 disease pairs, and interestingly musculoskeletal problem appeared among 3 of these 4 pairs.
The summary of the results of clusters is presented in Table 4.7. There were no clear patterns
observed in relation to patients characteristics and the attributes the data was clustered over.
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Diseases Combination
Age Group Socioeconomic Score
2 3 4 5 6 3 4 5
{Depression,Musculoskeletal Problem} X X X X X X X X
{Hypertension, Musculoskeletal Problem} - - X X X - X X
{Hypertension, Hyperlipidemia} - - X X X - X X
{Hypertension, Diabetes} - X X X X - X X
{Cancer, Musculoskeletal Problem} - X X X X - X X
{Cancer, Depression} - X X X X - X X
{Hypertension, Depression} - - X X X - X X
{Hypertension, Cancer} - - X X X - X X
{Hyperlipidemia, Musculoskeletal Problem} - - X X X X X X
{Bronchitis, Musculoskeletal Problem} X X X X X X X X
Table 4.6: The distribution of patient characteristics for individuals diagnosed with commonly
co-occurring disease pairs.
Clustering results rely on:
Diseases Combination Clusters Gender Age
Group
Socioeco-
nomic
Score
{Depression, Musculoskeletal Problem} 5 X
{Hypertension, Musculoskeletal Problem} 3 X X X
{Hypertension, Hyperlipidemia} 3 X X
{Hypertension, Diabetes} 4 X X
{Cancer, Musculoskeletal Problem} 3 X X
{Cancer, Depression} 4 X X
{Hypertension, Depression} 3 X X
{Hypertension, Cancer} 3 X X
{Hyperlipidemia, Musculoskeletal Problem} 3 X X X
{Bronchitis, Musculoskeletal Problem} 5 X X
Table 4.7: The summary of clustering results for 10 commonly curring disease pars. Every row
represents the summary of clustering results for one disease pair. The number of clusters which
minimize the within-cluster sum of squares are included in second column. The attributes upon
which the clustering has occurred are indicated with check marks.
4.4 Statistical Analysis of Three Coexisting Chronic Diseases
The chart in Figure 4.6 shows the percentage of middle aged or elder patients with any number
of chronic conditions. As the chart suggests, the distribution of patients with multimorbidity fo-
cuses more on older population as the number of coexisting chronic conditions grow. Accord-
ing to the chart, 91.53 percent of the patients who are defined as multimorbid by having three
chronic conditions are elder or middle aged. On the other hand, the absolute patient counts
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with multimorbidity decreases exponentially as the number of coexisting diseases per patient
grows. In the database of this research, there are 1926 patients in total from all age groups who
have three coexisting diseases. The limited number of instances who have many coexisting
chronic conditions, restricts the opportunity of further research. However, this section provides
some insight on demographic characteristics of patients with three chronic illnesses.
Figure 4.6: Multimorbidity occurs mostly among middle aged or elder patients, and it affects a
greater proportion of these two age groups as the number of coexisting diseases grows. 87.53%
of patients diagnosed with two chronic conditions are either middle aged or elder, and this
percentage grows with number of coexisting diseases, such that co-occurrence of 8 or more
diseases happens only among middle aged and elder patients.
The distribution of patients with three chronic diseases among males and females is 45.43%
and 54.57%, respectively. The variety of combinations for three co-occurring conditions among
patients is 493 based on the data in the DELPHI database. The most commonly occurring dis-
ease triples are listed in Table 4.8 and sorted based on patient counts.
The characteristics of patients diagnosed with common disease triples is represented in Ta-
ble 4.9. As the table suggests some of the disease triples (for instance 1st and 3rd combination)
occur among a greater variety of age groups and all socioeconomic score categories, whereas
the other combinations are more specific to older age groups and higher socioeconomic scores.
4.4. Statistical Analysis of Three Coexisting Chronic Diseases 71
Disease Combination Patient Counts
1 Hypertension, Diabetes and Hyperlipidemia 116
2 Hypertension, Hyperlipidemia and Cardiovascular Disease 75
3 Bronchitis, Depression and Musculoskeletal Problem 59
4 Hypertension, Diabetes and Cardiovascular Disease 28
5 Hypertension, Hyperlipidemia and Arthritis 24
6 Hypertension, Diabetes and Thyroid 22
7 Hypertension, Hyperlipidemia and Cancer 21
Table 4.8: The list shows most frequently occurring disease combinations derived from DEL-
PHI database. All disease combinations occurring among more than 20 patients are listed in
this table. Disease combinations are sorted by frequency of occurrence among patients. The
column Patient Counts represents the number of individuals with corresponding disease com-
bination in the DELPHI database.
Some of the combinations are more prevalent among males (such as 2nd combination), some
are more prevalent among female population (i.e. 6th disease combination), and there are com-
binations which are not specific to males or females, and occur among both genders almost
equally (3rd combination is an example). Almost 61.21% of the patients with one of these
disease combinations are male and the rest are female.
Diseases Combination
Age Group Socioeconomic Score Gender Counts
3 4 5 6 3 4 5 M F
1 {HT, DB, HL} X X X X X X X 71 45
2 {HT, HL, CD} - X X X - X X 54 21
3 {BC, DP, MP} X X X X X X X 31 28
4 {HT, DB, CD} - - X X - X X 17 11
5 {HT, HL, AT} - - X X - X X 10 14
6 {HT, DB, TD} - - X X - X X 4 18
7 {HT, HL, CC} - - X X - X X 16 5
Table 4.9: The distribution of patients characteristics for individuals diagnosed with commonly
co-occurring chronic disease triples. Abbreviations: M=Male, F=Female, HT=Hypertension,
DB=Diabetes, BC=Bronchitis, HL=Hyperlipidemia, CC=Cancer, CD=Cardiovascular Dis-
ease, DP=Depression, AT=Arthritis, TD=Thyroid, MP=Musculoskeletal Problem.
As the Risk Ratios suggest, patients are 4.9 times more likely to develop a third chronic
condition if they are diagnosed with any one of the commonly occurring disease pairs. On
the other hand, every one of the commonly occurring disease pairs is a subset of at least one
of the commonly co-occurring disease triples. In order to measure the association between
commonly occurring disease pairs and commonly occurring disease triples, we have calculated
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the multimorbidity coefficients for commonly occurring disease pairs and all twenty chronic
conditions to find out how likely it is for a patient to be diagnosed with any of the twenty
chronic conditions if they are already diagnosed with any one of the common disease pairs. The
results are presented in Table 4.10. According to the results, multimorbidity coefficients show
a high association between three of the common disease triples and disease pairs. For instance,
patients with hypertension and hyperlipidemia (one of the common disease pairs) are most
likely to be diagnosed with diabetes compared to all other diseases, and these three diseases
are one of the commonly occurring combinations among patients with three chronic illnesses.
The same association can be found among depression, musculoskeletal problem and bronchitis.
However, not all of the commonly occurring disease triples were shown to be highly associated
according to multimorbidity coefficients, and not all highly associated diseases according to
multimorbidity coefficients are among common combinations of three co-occurring diseases.
The rates of multimorbidity coefficients show the likelihood of diagnosis with a third chronic
disease for a patient with any one of the disease pairs to be diagnosed with a third chronic
condition: the higher the rate, the more is the prevalence of the corresponding disease triples
to occur.
According to disease association rates computed by multimorbidity coefficients, the com-
mon disease triples among patients in DELPHI database which do not appear to be highly asso-
ciated in the table, have appeared either due to coincidental multimorbidity, or lack of enough
data for examination, or any other medical related reasons which multimorbidity coefficients
are not taking into account.
The reason for choosing multimorbidity coefficients over the other pairwise association
measurement methods for measuring disease associations, is its ability to separate coincidental
multimorbidity (random multimorbidity) from disease co-occurrences by causal association
(non-random multimorbidity). The other pairwise disease association methods (such as odds
ratios or risk ratios) do not separate between random and non-random multimorbidity.
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Chapter 5
Conclusion
The main goal of the research underlying this thesis was to investigate, explore and identify
different approaches for analyzing socio-demographic characteristics of patients with multiple
chronic conditions, with a specific focus on patients sharing same chronic disease combina-
tions. This chapter provides an overview on approaches taken to analyze the burden of multi-
morbidity according to patients demographic characteristics. It summarizes potential similari-
ties and differences identified among patients diagnosed with same number of diseases focus-
ing on patient groups sharing the same combination of diseases, and concludes by providing
strengths and limitations of the research, as well as potential areas for future work.
5.1 Main Contributions
In this research, we demonstrated the applicability of analytical and clustering methods to
data about patients with multiple chronic diseases. The dataset used for analysis purposes
contains 13697 records of patients with one or more chronic conditions. Socio-demographic
information extracted for every patient are gender, age group, and socioeconomic score. The
methods explored include disease counts, pairwise association measurement approaches (e.g.
odds ratios, risk ratios and multimorbidity coefficients), and clustering algorithms (k−modes
was the primary algorithm used for analysis in this research). Besides exploring analytical
methods, we have also suggested different visualization approaches for representing the data
of patients with multimorbidity, which includes representation of patients socio-demographic
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characteristics and their relationships.
In order to explore relationships between certain chronic conditions and patient demo-
graphic characteristics, prevalence and distribution of diseases were analyzed for every chronic
disease separately over gender, six age groups and three socioeconomic scores among patients
diagnosed with one or more chronic conditions. The results suggest that age is important in
the prevalence of occurrences of multimorbidity: Older age groups had more occurrences of
multiple chronic conditions compared to younger groups. Some diseases appeared to be age-
associated, whereas some others did not.
Pairwise co-occurrence rates of chronic diseases was computed using multimorbidity co-
efficients (MC), and it was shown that certain combinations (disease pairs) are very likely to
co-occur compared to others. Disease pair counts showed that some of the highly associated
disease pairs according to MC were frequently occurring among patients; an example of this
is the pair hypertension and hyperlipidemia. Disease pair distributions were also computed
for males and females, all age groups and all socioeconomic score levels separately. The re-
sults suggest that some diseases occur more often with a second disease among males (e.g.
hypertension) and some among females (e.g. thyroid). The variation of disease combinations
grows by age, and for every age group there are certain disease combinations which tend to
occur more compared to other age groups. Disease pair distribution results for patients from
socioeconomic score 3 were less varying compared to scores 4 and 5, and the latter two scores
suggested a similar distribution to total disease pair distributions, with no visible dissimilarities.
To further explore patient characteristics with same diseases, we clustered patients with
certain disease pair combinations. The observations suggest that gender plays a role in dividing
patients into clusters in every disease pair, and age group in most of them, while socioeconomic
score plays a role in division of clusters mostly among pairs where musculoskeletal problems
are one of the two diseases.
Finally, patients’ socio-demographic characteristics were analyzed for individuals diag-
nosed with three chronic conditions. The overall analysis of this group showed that diagnosis
of three chronic conditions mainly appears among middle aged and elder population. Accord-
ing to disease counts, the most frequently co-occurring diseases are hypertension, diabetes and
hyperlipidemia. Multimorbidity coefficients measured the concurrence between commonly co-
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occurring disease pairs and all eighteen other diseases, and it was shown that some of the highly
associated triples (according to MC) were also commonly occurring in patients of this dataset
(according to disease counts), were a subset of commonly co-occurring disease pairs.
One of the secondary contributions of this research was to identify socio-demographic score
for patients from a different data source and tie it to each patient in main database given the
lack of these attributes in original data-set. This approach can be applied to similar data-sets
(which are greater in size) to investigate the burden of multimorbidity, although the socioe-
conomic score (as measured) did not appear to be directly associated with co-occurrence of
multiple chronic condition according to our dataset due to following reasons: (1) high level
of abstraction in defining socioeconomic score; (2)lack of availability of socio-demographic
attributes; (3) lack of data.
5.2 Strengths, Limitations and Implications of the Research
Despite numerous past and ongoing research about the prognosis, diagnosis and overall burden
of multimorbidity, there is very little known about characteristics of patients with multimorbid-
ity. This research is among the first of its kind exploring methods for analyzing multimorbidity
data, focusing on patient groups sharing the same combination of diseases. There were chal-
lenges and limitations during the course of this research, which will be pointed out in the
following, along with assumptions, estimations and strategies used to overcome them.
Small dataset: In order to get reliable results from analyzing patient data, the main re-
quirement is having access to data with sufficient numbers of patients with multimorbidity.
The DELPHI database contained 7394 patients with multimorbidity at the time of extraction.
However, the available amount of data drops dramatically when extracting the information of
patients with a certain number and certain combination of diseases. This was a limitation for
further exploration of dataset. Due to the small number of available data we were only able to
explore the demographic characteristics of patients with certain and most occurring combina-
tions of diseases.
Lack of availability of socioeconomic attributes: It is commonly seen that regardless
of the source of medical data, socioeconomic variables usually contain incomplete or miss-
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ing attributes that cannot be used in statistical analysis. Although, each patient’s gender, age,
and residential area were collected from the database, these attributes do not account for so-
cioeconomic factors that impact or are affected by health. As we needed a metric identifying
the economic status of patients along side the other variables, we have extracted median fam-
ily income levels of individuals for all FSAs from a different source and matched it with the
residential area of patients in our dataset. The final socioeconomic score was computed by
matching the FSA-based median family income to the FSA of individuals in DELPHI database
which contains a high level of abstraction and makes the results prone to external criticism.
Complex reality of multimorbidity: As discussed in Chapter 2, the phenomenon of mul-
timorbidity is very complex. There are many aspects that can play a role in patients health out-
comes. Patients’ educational background, current and past occupations, smoking and drinking
habits, distress levels, ethnic background, cultural and environmental effects are some exam-
ples of factors that can affect or be affected by the prevalence of multimorbidity. Collecting this
information for patients in a database is a tedious and challening process. However, assuming
all these variables are accessible, the question become how to aggregate these factors into sin-
gle attributes/variables and how to summarize them to compute the socioeconomic score? The
other question is how to identify whether a socioeconomic factor is impacting health outcomes
or being affected by health-related complications? Although the scoring system can enable
the opportunity to perform computational research on multimorbidity, the research in this area
has still a long way to go to create a reliable scoring system for computing the socioeconomic
burden of multimorbidity.
5.3 Future Research
There are many opportunities for improving this research as well as further analysis of multi-
morbid patient data, some of which are provided in this section.
Usage of a larger dataset: Some of the limitations in this research were due to lack of data
for multimorbid patients. For instance, we have overgeneralized the metric used in computation
of socioeconomic score due to lack of availability of socioeconomic variables. Furthermore,
lack of sufficient records for patients with more than three diseases, restricted the opportunity to
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perform further exploration on demographic characteristics of patients with a greater number
of diseases. With a larger dataset, it is possible to do further and more precise analysis on
characteristics of multimorbid patients.
Applying multimorbidity measurement approaches on time series data: It is also im-
portant to have access to information on patients over a duration of time. Analysis of sequential
data on patients’ diagnosis and socioeconomic status over periods of time can also help under-
stand the complexity of multimorbidity by helping to identify key factors and life changes that
may affect the occurrence of multimorbidity and to understand the effects multimorbidity have
on quality of life.
Exploring co-occurring disease combinations among patients with same socio-demo-
graphic characteristics: Beside exploring the distribution of diseases (or disease pairs) for all
age groups, socioeconomic scores, and the gender separately, we have analyzed and clustered
socio-demographic characteristics of patients with same number (as well as same combina-
tion) of chronic conditions. However, analyzing and clustering the distribution of different
disease counts and combinations for all patients belonging to the same gender, age group and
socioeconomic status would be another interesting approach in analyzing multimorbid patient
data.
Replacing disease counts with pairwise associations measurement methods: In order
to define highly associated disease pairs, we have used absolute disease pair counts, and ten of
the most commonly occurring pairs were used for clustering. Although, it is also possible to
derive highly associated diseases using the pairwise association measurement methods, such
as risk ratios, multimorbidity coefficients or Kappa statistics methods. These measurement
methods provide a more precise notion on disease associations compared to absolute counts.
However, the reason for choosing counts over these methods was insufficient available data for
most of the highly associated disease pairs defined by pairwise association methods.
Applying other clustering methods: Our approach for clustering patients with common
disease pair using modified version of k−modes may benefit from further exploration and com-
parison with results of other clustering approaches. By using Factor Analysis methods it is also
possible to identify the type of disease associations and their corresponding risk factors (the
causation models for two diseases and their risk factors are presented in Figure 1.3).
Bibliography
[1] Nancy E Adler, Thomas Boyce, Margaret A Chesney, Sheldon Cohen, Susan Folkman,
Robert L Kahn, and S Leonard Syme. Socioeconomic status and health: the challenge
of the gradient. American psychologist, 49(1):15, 1994.
[2] Daniel Aloise, Amit Deshpande, Pierre Hansen, and Preyas Popat. Np-hardness of eu-
clidean sum-of-squares clustering. Machine learning, 75(2):245–248, 2009.
[3] Gerard F Anderson. Chronic care: making the case for ongoing care. Robert Wood
Johnson Foundation, 2010.
[4] Karen Barnett, Stewart W Mercer, Michael Norbury, Graham Watt, Sally Wyke, and
Bruce Guthrie. Epidemiology of multimorbidity and implications for health care, re-
search, and medical education: a cross-sectional study. The Lancet, 380(9836):37–43,
2012.
[5] L Batstra, EH Bos, and J Neeleman. Quantifying psychiatric comorbidity. Social psy-
chiatry and psychiatric epidemiology, 37(3):105–111, 2002.
[6] Elizabeth A Bayliss, Jennifer L Ellis, and John F Steiner. Subjective assessments of
comorbidity correlate with quality of life health outcomes: initial validation of a comor-
bidity assessment instrument. Health and Quality of life Outcomes, 3(1):1, 2005.
[7] Joseph Berkson. Limitations of the application of fourfold table analysis to hospital
data. Biometrics Bulletin, 2(3):47–53, 1946.
[8] Rob V Bijl, Anneloes Ravelli, and G Van Zessen. Prevalence of psychiatric disorder
in the general population: results of the netherlands mental health survey and inci-
dence study (nemesis). Social psychiatry and psychiatric epidemiology, 33(12):587–
595, 1998.
[9] Richard V Birtwhistle. Canadian primary care sentinel surveillance network a devel-
oping resource for family medicine and public health. Canadian Family Physician,
57(10):1219–1220, 2011.
[10] Norman Blaikie. Analyzing quantitative data: From description to explanation. Sage,
2003.
[11] Ruth Bonita, Robert Beaglehole, and Tord Kjellström. Basic epidemiology. World
Health Organization, 2006.
79
80 BIBLIOGRAPHY
[12] Andrew Booth. " brimful of starlite": toward standards for reporting literature searches*.
Journal of the Medical Library Association, 94(4):421, 2006.
[13] Cynthia M Boyd, MD Martin Fortin, et al. Future of multimorbidity research: how
should understanding of multimorbidity inform health system design? Public Health
Reviews, 32(2):1, 2010.
[14] Rodolfo A Bulatao, Norman B Anderson, et al. Understanding racial and ethnic differ-
ences in health in late life: A research agenda. National Academies Press, 2004.
[15] Julie E Byles, Catherine D’Este, Lynne Parkinson, Rachel O’Connell, and Carla Treloar.
Single index of multimorbidity did not predict multiple outcomes. Journal of clinical
epidemiology, 58(10):997–1005, 2005.
[16] Patrick Cain. Income by postal code: Mapping Canada’s richest and poorest neighbour-
hoods. http://globalnews.ca/news/370804/income-by-postal-code/, 2013.
[17] Statistics Canada. Average adjusted after-tax income by after-tax income quintiles for
all persons, 2006 to 2010. http://www.statcan.gc.ca/pub/75-202-x/2010000/
analysis-analyses-eng.htm, 2010.
[18] Mary E Charlson, Peter Pompei, Kathy L Ales, and C Ronald MacKenzie. A new
method of classifying prognostic comorbidity in longitudinal studies: development and
validation. Journal of chronic diseases, 40(5):373–383, 1987.
[19] Domenic V Cicchetti and Alvan R Feinstein. High agreement but low kappa: Ii. resolv-
ing the paradoxes. Journal of clinical epidemiology, 43(6):551–558, 1990.
[20] Thomas Claassen. Causal discovery and logic. UB Nijmegen [host], 2013.
[21] Alexander M Clark, Marie DesMeules, Wei Luo, Amanda S Duncan, and Andy Wiel-
gosz. Socioeconomic status and cardiovascular disease: risks and implications for care.
Nature Reviews Cardiology, 6(11):712–722, 2009.
[22] Aileen Clarke. What is a chronic disease? the effects of a re-definition in hiv and aids.
Social Science & Medicine, 39(4):591–597, 1994.
[23] Jacob Cohen. Weighted kappa: Nominal scale agreement provision for scaled disagree-
ment or partial credit. Psychological bulletin, 70(4):213, 1968.
[24] WONCA Classification Committee et al. Ichppc-2-defined (international classification
of health problems in primary care, 1983.
[25] William Corser, Alla Sikorskii, Ade Olomu, Manfred Stommel, Camille Proden, and
Margaret Holmes-Rovner. Concordance between comorbidity data from patient self-
report interviews and medical record documentation. BMC Health Services Research,
8(1):1, 2008.
[26] National Research Council, Committee on Population, et al. Critical perspectives on
racial and ethnic differences in health in late life. National Academies Press, 2004.
BIBLIOGRAPHY 81
[27] HL Crabtree, CS Gray, AJ Hildreth, JE O’Connell, and J Brown. The comorbidity
symptom scale: a combined disease inventory and assessment of symptom severity.
Journal of the American Geriatrics Society, 48(12):1674–1678, 2000.
[28] Eileen M Crimmins, Mark D Hayward, and Teresa E Seeman. Race/ethnicity, socioeco-
nomic status, and health. Critical perspectives on racial and ethnic differences in health
in late life, pages 310–352, 2004.
[29] Jetty AA Dalstra, Anton E Kunst, Carme Borrell, Elizabeth Breeze, Emmanuelle Cam-
bois, Giuseppe Costa, José JM Geurts, Eero Lahelma, Herman Van Oyen, Niels K Ras-
mussen, et al. Socioeconomic differences in the prevalence of common chronic dis-
eases: an overview of eight european countries. International journal of epidemiology,
34(2):316–326, 2005.
[30] R Davis, E Wagner, and Trish Groves. Patients as partners in managing chronic disease.
Bmj, 320:526–527, 2000.
[31] Vincent de Groot, Heleen Beckerman, Gustaaf J Lankhorst, and Lex M Bouter. How
to measure comorbidity: a critical review of available methods. Journal of clinical
epidemiology, 56(3):221–229, 2003.
[32] Joseph AC Delaney and John D Seeger. Sensitivity analysis. Agency for Healthcare
Research and Quality (US), 2013.
[33] Claudia Diederichs, Klaus Berger, and Dorothee B Bartels. The measurement of multi-
ple chronic diseases-a systematic review on existing multimorbidity indices. The Jour-
nals of Gerontology Series A: Biological Sciences and Medical Sciences, 66(3):301–
311, 2011.
[34] Hal A Droogleever Fortuyn, Rolf Fronczek, Mirjan Smitshoek, Sebastiaan Overeem,
Martijn Lappenschaar, Joke Kalkman, Willy Renier, Jan Buitelaar, Gert Jan Lammers,
and Gijs Bleijenberg. Severe fatigue in narcolepsy with cataplexy. Journal of sleep
research, 21(2):163–169, 2012.
[35] Benjamin G Druss, Steven C Marcus, Mark Olfson, Terri Tanielian, Lynn Elinson, and
Harold Alan Pincus. Comparing the national economic burden of five chronic condi-
tions. Health Affairs, 20(6):233–241, 2001.
[36] Susan A Everson, Siobhan C Maty, John W Lynch, and George A Kaplan. Epidemi-
ologic evidence for the relation between socioeconomic status and depression, obesity,
and diabetes. Journal of psychosomatic research, 53(4):891–895, 2002.
[37] Martine Extermann. Measurement and impact of comorbidity in older cancer patients.
Critical reviews in oncology/hematology, 35(3):181–200, 2000.
[38] Vincent S Fan, David Au, Patrick Heagerty, Richard A Deyo, Mary B McDonell, and
Stephan D Fihn. Validation of case-mix measures derived from self-reports of diagnoses
and health. Journal of clinical epidemiology, 55(4):371–380, 2002.
82 BIBLIOGRAPHY
[39] Alvan R Feinstein. The pre-therapeutic classification of co-morbidity in chronic disease.
Journal of chronic diseases, 23(7):455–468, 1970.
[40] Alvan R Feinstein and Domenic V Cicchetti. High agreement but low kappa: I. the
problems of two paradoxes. Journal of clinical epidemiology, 43(6):543–549, 1990.
[41] Alexis Ferré, Claire Fuhrman, Mahmoud Zureik, Christos Chouaid, Alain Vergnenègre,
Gérard Huchon, Marie-Christine Delmas, and Nicolas Roche. Chronic bronchitis in the
general population: influence of age, gender and socio-economic conditions. Respira-
tory medicine, 106(3):467–471, 2012.
[42] Robert H Fletcher, Suzanne W Fletcher, and Grant S Fletcher. Clinical epidemiology:
the essentials. Lippincott Williams & Wilkins, 2012.
[43] Patient-Centred Innovations for Persons with Multimorbidity. PACE in MM. http:
//paceinmm.recherche.usherbrooke.ca/index.php, 2014.
[44] Martin Fortin, Lise Lapointe, Catherine Hudon, and Alain Vanasse. Multimorbidity is
common to family practice: is it commonly researched? Canadian Family Physician,
51(2):244–245, 2005.
[45] Martin Fortin, Hassan Soubhi, Catherine Hudon, Elizabeth A Bayliss, and Marjan
van den Akker. Multimorbidity’s many challenges. bmj, 334(7602):1016–1017, 2007.
[46] Ha Droogleever Fortuyn, GA Lappenschaar, JW Furer, and PP Hodiamont. Anxiety and
mood disorders in narcolepsy. aspects of the psychiatric phenotype, 32:49–56, 2011.
[47] Linda P Fried, Karen Bandeen-Roche, Judith D Kasper, Jack M Guralnik, et al. Associ-
ation of comorbidity with disability in older women: the womenâA˘Z´s health and aging
study. Journal of clinical epidemiology, 52(1):27–37, 1999.
[48] Johnson George, Tam Vuong, Michael J Bailey, David CM Kong, Jennifer L Marriott,
and Kay Stewart. Development and validation of the medication-based disease burden
index. Annals of Pharmacotherapy, 40(4):645–650, 2006.
[49] Dana P Goldman and James P Smith. Can patient self-management help explain the
ses health gradient? Proceedings of the National Academy of Sciences, 99(16):10929–
10934, 2002.
[50] Sheldon Greenfield, Giovanni Apolone, Barbara J McNeil, and Paul D Cleary. The
importance of co-existent disease in the occurrence of postoperative complications and
one-year recovery in patients undergoing total hip replacement: comorbidity and out-
comes after hip replacement. Medical care, 31(2):141–154, 1993.
[51] Agneta Grimby and Alvar Svanborg. Morbidity and health-related quality of life among
ambulant elderly citizens. Aging Clinical and Experimental Research, 9(5):356–364,
1997.
BIBLIOGRAPHY 83
[52] Dianne L Groll, Teresa To, Claire Bombardier, and James G Wright. The development
of a comorbidity index with physical function as the outcome. Journal of clinical epi-
demiology, 58(6):595–602, 2005.
[53] Stephen F Hall. A user’s guide to selecting a comorbidity index for clinical research.
Journal of clinical epidemiology, 59(8):849–855, 2006.
[54] Greg Hamerly and Charles Elkan. Alternatives to the k-means algorithm that find better
clusterings. In Proceedings of the eleventh international conference on Information and
knowledge management, pages 600–607. ACM, 2002.
[55] Catherine Hoffman, Dorothy Rice, and Hai-Yen Sung. Persons with chronic conditions:
their prevalence and costs. Jama, 276(18):1473–1479, 1996.
[56] Libby Holden, Paul A Scuffham, Michael F Hilton, Alexander Muspratt, Shu-Kay Ng,
and Harvey A Whiteford. Patterns of multimorbidity in working australians. Population
health metrics, 9(1):15, 2011.
[57] Zhexue Huang. Clustering large data sets with mixed numeric and categorical values.
In Proceedings of the 1st pacific-asia conference on knowledge discovery and data min-
ing,(PAKDD), pages 21–34. Citeseer, 1997.
[58] Zhexue Huang. Extensions to the k-means algorithm for clustering large data sets with
categorical values. Data mining and knowledge discovery, 2(3):283–304, 1998.
[59] Soiya M Hunt and James McEwen. The development of a subjective health indicator.
Sociology of health & illness, 2(3):231–246, 1980.
[60] Mary Inaba, Naoki Katoh, and Hiroshi Imai. Applications of weighted voronoi diagrams
and randomization to variance-based k-clustering. In Proceedings of the tenth annual
symposium on Computational geometry, pages 332–339. ACM, 1994.
[61] R Antonelli Incalzi, O Capparella, A Gemma, F Landi, E Bruno, F Di Meo, and P Car-
bonin. The interaction between age and comorbidity contributes to predicting the mor-
tality of geriatric patients in the acute-care hospital. Journal of internal medicine,
242(4):291–298, 1997.
[62] Rachel Jenkins, G Lewis, P Bebbington, T Brugha, M Farrell, B Gill, and H Meltzer. The
national psychiatric morbidity surveys of great britain–initial findings from the house-
hold survey. Psychological medicine, 27(04):775–789, 1997.
[63] Robert J Johnson and Fredric D Wolinsky. The structure of health status among older
adults: disease, disability, functional limitation, and perceived health. Journal of health
and social behavior, pages 105–121, 1993.
[64] UT Kadam, PR Croft, et al. Clinical multimorbidity and physical function in older
adults: a record and health status linkage study in general practice. Family practice,
24(5):412–419, 2007.
84 BIBLIOGRAPHY
[65] David Kalisch. The 14th biennial health report of the australian institute of health and
welfare. Technical report, Australian Institution of Health and Welfare, 06 2014.
[66] Moreson H Kaplan and Alvan R Feinstein. The importance of classifying initial co-
morbidity in evaluating the outcome of diabetes mellitus. Journal of chronic diseases,
27(7):387–404, 1974.
[67] Jeffrey N Katz, Lily C Chang, Oliver Sangha, Anne H Fossel, and David W Bates. Can
comorbidity be measured by questionnaire rather than medical record review? Medical
care, 34(1):73–84, 1996.
[68] Jay S Kaufman, Richard S Cooper, and Daniel L McGee. Socioeconomic status and
health in blacks and whites: the problem of residual confounding and the resiliency of
race. Epidemiology, pages 621–628, 1997.
[69] Grace Kena. National center for education statistics, 2008.
[70] Zhao S Nelson CB Hughes M Eshleman S Wittchen HU Kessler RC, McGonagle KA
and Kendler KS. Lifetime and 12-month prevalence of dsm-iii-r psychiatric disorders
in the united states: Results from national comorbidity survey. Arch Gen Psychiatry,
51(1):8–19, 1994.
[71] Raynard S Kington and Herbert W Nickens. Racial and ethnic differences in health:
recent trends, current patterns, future directions. America becoming: Racial trends and
their consequences, 2:253–310, 2001.
[72] Inge Kirchberger, Christa Meisinger, Margit Heier, Anja-Kerstin Zimmermann, Bar-
bara Thorand, Christine S Autenrieth, Annette Peters, Karl-Heinz Ladwig, and Angela
Döring. Patterns of multimorbidity in the aged population. results from the kora-age
study. PloS one, 7(1):e30556, 2012.
[73] Rex Kline, Y Petscher, and C Schatschneider. Exploratory and confirmatory factor anal-
ysis. Applied quantitative analysis in the social sciences, pages 171–207, 2013.
[74] Eugene F Krause. Taxicab geometry: An adventure in non-Euclidean geometry. Courier
Corporation, 2012.
[75] Lewis H Kuller. Relationship between acute and chronic disease epidemiology. The
Yale journal of biology and medicine, 60(4):363, 1987.
[76] Martijn Lappenschaar. New network models for the analysis of disease interaction with
applications in multimorbidity. PhD thesis, Radbound University, 2014.
[77] Himmelfarb Health Sciences Library. Study Design 101 case-control
study. http://web.archive.org/web/20080207010024/http://www.
808multimedia.com/winnt/kernel.htmhttps://himmelfarb.gwu.edu/
tutorials/studydesign101/casecontrols.html. Accessed: 2011-10-01.
BIBLIOGRAPHY 85
[78] Bernard S Linn, MARGARET W LINN, and LEE Gurel. Cumulative illness rating
scale. Journal of the American Geriatrics Society, 16(5):622–626, 1968.
[79] Meena Mahajan, Prajakta Nimbhorkar, and Kasturi Varadarajan. The planar k-means
problem is np-hard. In International Workshop on Algorithms and Computation, pages
274–285. Springer, 2009.
[80] Alessandra Marengoni, Debora Rizzuto, Hui-Xin Wang, Bengt Winblad, and Laura
Fratiglioni. Patterns of chronic multimorbidity in the elderly population. Journal of
the American Geriatrics Society, 57(2):225–230, 2009.
[81] Scott Wallask Margaret Rouse. Icd-10(international classification of diseases, tenth re-
vision), 2015.
[82] Colin Mathers, Theo Vos, and Chris Stevenson. The burden of disease and injury in
Australia. Australian Institute of Health and Welfare, 1999.
[83] Daniel McGee, Richard Cooper, Youlian Liao, and Ramon Durazo-Arvizu. Patterns of
comorbidity and mortality risk in blacks and whites. Annals of epidemiology, 6(5):381–
385, 1996.
[84] Gary McLean, Jane Gunn, Sally Wyke, Bruce Guthrie, Graham CM Watt, David N
Blane, and Stewart W Mercer. The influence of socioeconomic deprivation on multi-
morbidity at different ages: a cross-sectional study. Br J Gen Pract, 64(624):e440–e447,
2014.
[85] Merriam-Webster. Merriam-Webster’s collegiate dictionary. Merriam-Webster, 2004.
[86] Jane E Miller. The effects of race/ethnicity and income on early childhood asthma preva-
lence and health care use. American Journal of Public Health, 90(3):428, 2000.
[87] Michael C Neale and Kenneth S Kendler. Models of comorbidity for multifactorial
disorders. American journal of human genetics, 57(4):935, 1995.
[88] Anne B Newman, Robert M Boudreau, Barbara L Naydeck, Linda F Fried, and
Tamara B Harris. A physiologic index of comorbidity: relationship to mortality and
disability. The Journals of Gerontology Series A: Biological Sciences and Medical Sci-
ences, 63(6):603–609, 2008.
[89] Shu Kay Ng, Libby Holden, and Jing Sun. Identifying comorbidity patterns of health
conditions via cluster analysis of pairwise concordance statistics. Statistics in medicine,
31(27):3393–3405, 2012.
[90] Kathryn Nicholson, Amanda L Terry, Martin Fortin, Tyler Williamson, Michael Bauer,
and Amardeep Thind. Examining the prevalence and patterns of multimorbidity in cana-
dian primary healthcare: a methodologic protocol using a national electronic medical
record database. Journal of Comorbidity, 5(1):150–161, 2015.
86 BIBLIOGRAPHY
[91] Government of Canada. Forward Sortation Area–Definition. https://www.ic.gc.
ca/eic/site/bsf-osb.nsf/eng/br03396.html, 2016.
[92] Julie O’Halloran, Graeme C Miller, and Helena Britt. Defining chronic conditions for
primary care with icpc-2. Family Practice, 21(4):381–386, 2004.
[93] World Health Organization. International classification of disease (icd). http://www.
who.int/classifications/icd/en/. Accessed: 2011-06-29.
[94] Ellen C Perrin, Paul Newacheck, I Barry Pless, Dennis Drotar, Steven L Gortmaker, John
Leventhal, James M Perrin, Ruth EK Stein, Deborah K Walker, and Michael Weitzman.
Issues involved in the definition and classification of chronic health conditions. Pedi-
atrics, 91(4):787–793, 1993.
[95] Alexandra Prados-Torres, Beatriz Poblador-Plou, Amaia Calderón-Larrañaga, Luis An-
drés Gimeno-Feliu, Francisca González-Rubio, Antonio Poncel-Falcó, Antoni Sicras-
Mainar, and José Tomás Alcalá-Nalvaiz. Multimorbidity patterns in primary care: inter-
actions among chronic diseases using factor analysis. PloS one, 7(2):e32190, 2012.
[96] Henri Ralambondrainy. A conceptual version of the k-means algorithm. Pattern Recog-
nition Letters, 16(11):1147–1157, 1995.
[97] Soo Hyun Rhee, John K Hewitt, Jeffrey M Lessem, Michael C Stallings, Robin P Corley,
and Michael C Neale. The validity of the neale and kendler model-fitting approach in
examining the etiology of comorbidity. Behavior Genetics, 34(3):251–265, 2004.
[98] Richard G Rogers, Robert A Hummer, and Charles B Nam. Living and dying in the
USA: Behavioral, health, and social differentials of adult mortality. Elsevier, 1999.
[99] Monika M Safford, Jeroan J Allison, and Catarina I Kiefe. Patient complexity: more
than comorbidity. the vector model of complexity. Journal of General Internal Medicine,
22(3):382–390, 2007.
[100] Ingmar Schäfer, Heike Hansen, Gerhard Schön, Susanne Höfels, Attila Altiner, Anne
Dahlhaus, Jochen Gensichen, Steffi Riedel-Heller, Siegfried Weyerer, Wolfgang A
Blank, et al. The influence of age, gender and socio-economic status on multimor-
bidity patterns in primary care. first results from the multicare cohort study. BMC health
services research, 12(1):1, 2012.
[101] Benjamin Schüz, Susanne Wurm, Lisa M Warner, and Clemens Tesch-Römer. Health
and subjective well-being in later adulthood: Different health states-different needs?
Applied Psychology: Health and Well-Being, 1(1):23–45, 2009.
[102] Nova Scotia. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry, 19:227,
2010.
[103] Teresa E Seeman and Eileen Crimmins. Social environment effects on health and aging.
Annals of the New York Academy of Sciences, 954(1):88–117, 2001.
BIBLIOGRAPHY 87
[104] J Smith. Chronic diseases related to aging and health promotion and disease prevention.
Report of the Standing Committee on Health, 75, 2012.
[105] James P Smith. Healthy bodies and thick wallets: the dual relation between health
and economic status. The journal of economic perspectives: a journal of the American
Economic Association, 13(2):144, 1999.
[106] Susan M Smith and Tom O’Dowd. Chronic diseases: what happens when they come in
multiples? Br J Gen Pract, 57(537):268–270, 2007.
[107] Jaapjan D Snoep, Alfredo Morabia, Sonia Hernández-Díaz, Miguel A Hernán, and Jan P
Vandenbroucke. Commentary: A structural approach to berkson’s fallacy and a guide
to a history of opinions about it. International journal of epidemiology, page dyu026,
2014.
[108] Hassan Soubhi, Martin Fortin, and Catherine Hudon. Perceived conflict in the couple
and chronic illness management: preliminary analyses from the quebec health survey.
BMC family practice, 7(1):1, 2006.
[109] Charles Spearman. " general intelligence," objectively determined and measured. The
American Journal of Psychology, 15(2):201–292, 1904.
[110] Ruth EK Stein, Laurie J Bauman, Lauren E Westbrook, Susan M Coupey, and Henry T
Ireys. Framework for identifying children who have chronic conditions: the case for a
new definition. The Journal of pediatrics, 122(3):342–347, 1993.
[111] Ruth EK Stein and Dorothy Jones Jessop. What diagnosis does not tell: the case for
a noncategorical approach to chronic illness in childhood. Social science & medicine,
29(6):769–778, 1989.
[112] Moira Stewart. CPCSSN(Canadian Primary Care Sentinel Surveil-
lance Network) Project. http://cpcssn.ca/regional-networks/
delphi-deliver-primary-healthcare-information-project/, 2016. [Cana-
dian Primary Care Sentinel Surveillance Network;].
[113] Moira Stewart. DELPHI(Deliver Primary Healthcare Information) Project. http://
cpcssn.ca/research-resources/cpcssn-data-for-research/, 2016. [Cana-
dian Primary Care Sentinel Surveillance Network;].
[114] Moira Stewart, Amardeep Thind, Amanda L Terry, Vijaya Chevendra, and J Neil Mar-
shall. Implementing and maintaining a researchable database from electronic medical
records: a perspective from an academic family medicine department. Healthcare Pol-
icy, 5(2):26, 2009.
[115] Stephanie R Susser, Jane McCusker, and Eric Belzile. Comorbidity information in older
patients at an emergency visit: self-report vs. administrative data had poor agreement
but similar predictive validity. Journal of clinical epidemiology, 61(5):511–515, 2008.
88 BIBLIOGRAPHY
[116] Leigh Tooth, Richard Hockey, Julie Byles, and Annette Dobson. Weighted multimor-
bidity indexes predicted mortality, health service use, and health-related quality of life
in older women. Journal of clinical epidemiology, 61(2):151–159, 2008.
[117] Derrick Vail. Dorland’s illustrated medical dictionary, 1957.
[118] Jose M Valderas, Barbara Starfield, Bonnie Sibbald, Chris Salisbury, and Martin Roland.
Defining comorbidity: implications for understanding health and health services. The
Annals of Family Medicine, 7(4):357–363, 2009.
[119] Marjan van den Akker, Frank Buntinx, and J André Knottnerus. Comorbidity or multi-
morbidity: what’s in a name? a review of literature. The European Journal of General
Practice, 2(2):65–70, 1996.
[120] Marjan Van den Akker, Frank Buntinx, Job FM Metsemakers, Sjef Roos, and J André
Knottnerus. Multimorbidity in general practice: prevalence, incidence, and determi-
nants of co-occurring chronic and recurrent diseases. Journal of clinical epidemiology,
51(5):367–375, 1998.
[121] Anthony J Viera, Joanne M Garrett, et al. Understanding interobserver agreement: the
kappa statistic. Fam Med, 37(5):360–363, 2005.
[122] Michael Von Korff, Edward H Wagner, and Kathleen Saunders. A chronic disease score
from automated pharmacy data. Journal of clinical epidemiology, 45(2):197–203, 1992.
[123] David F Warner and Mark D Hayward. Early-life origins of the race gap in men’s
mortality. Journal of health and social behavior, 47(3):209–226, 2006.
[124] Verne Wheelwright. It’s Your Future... Make It a Good One! Personal Futures Network,
2010.
[125] David R Williams and Chiquita Collins. Us socioeconomic and racial differences in
health: patterns and explanations. Annual review of sociology, pages 349–386, 1995.
[126] Jennifer L Wolff, Barbara Starfield, and Gerard Anderson. Prevalence, expenditures,
and complications of multiple chronic conditions in the elderly. Archives of internal
medicine, 162(20):2269–2276, 2002.
Appendices
89
Appendix A
Additional Material and Results
The extra figures and tables belonging to the analysis in this research are provided here. The
tables and figures included in this appendix represent the distribution of chronic diseases over
socio-demographic attributes with different aspects. Figures A.1 A.2 refer to patients diagnosed
with one of more chronic conditions, while Figures A.3 to A.13 represent the characteristics of
patients with two chronic conditions.
Theorem 1. The function d(S,q) is minimised if and only if fr(A j = q j|S ) ≥ fr(A j = ck, j|S ) for
q j , ck, j for all j = 1, ...,m, where fr(A j = ck, j|S ) =
nck, j
n
stands for the relative frequency of
k−th category ck, j in attribute A j from set S .
Proof. Assume that n is the total number of instances and m is the number of attributes for
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each instance in set S . According to , we have:
d(S , q) =
n∑
i=1
η(si, q)
=
n∑
i=1
m∑
j=1
η(si, j, q j)
=
m∑
j=1
n∑
i=1
η(si, j, q j)
=
m∑
j=1
[η(s1, j, q j) + η(s2, j, q j) + ... + η(sn, j, q j)]
=
m∑
j=1
fr(A j = q j|S )
=
m∑
j=1
(n − nq j)
=
m∑
j=1
n(1 − nq j
n
)
=
m∑
j=1
n(1 − fr(A j = q j|S ))
As we know
nq j
n
is a positive number lying between zero and one, as a results n(1 − fr(A j =
q j)|S ) ≥ 0 for 1 ≤ j ≤ m. Therefore d(S , q) is minimized if and only if n(1 − fr(A j = q j)|S ) is
minimal. For achieving this, fr(A j = q j|S ) must be maximal1. 
1Proof of Theorem 1 was derived from [58].
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D
isease
Index
C
hronic
D
isease
C
ategory
IC
D
-9
C
odes
1
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ypertension
401–405,401,401.1,401.9,405,405.01,405.09,405.1,405.11,405.19,405.9,405.91,
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2
O
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3
D
iabetes
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4
B
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493.92,
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5
H
yperlipidem
ia
272,272.1,272.2,272.3,272.4
6
C
ancer
140-239,140-149,150-159,160-165,170-176,179-189,190-199,200-209
7
C
ardiovascularD
isease
412,413,413.1,413.2,440-449,427,427.3,427.31,417.32
8
H
eartFailure
428,394,394.1,394.2,395,395.1,395.2,395.9
9
D
epression
296,
296.2,
296.21,
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296.31,
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Figure
A
.2:D
isease
percentages
forallage
groups
and
individualdiseases
based
on
gender.A
ccording
to
the
charts,som
e
diseases
have
the
sam
e
trend
of
grow
th
am
ong
m
ales
and
fem
ales
(e.g.
hypertension,diabetes,heartfailure,kidney
disease
and
stom
ach
problem
),
w
hiles
som
e
otherdiseases
follow
differenttrends
form
ales
and
fem
ales
(i.e.
obesity,cancerand
urinary
problem
).
Som
e
disease
tend
to
appear
w
ith
a
higher
frequency
am
ong
fem
ales
(e.g.
depression,thyroid,and
stom
ach
problem
),w
hile
som
e
tend
to
appear
m
ore
am
ong
m
ales
(e.g.dem
entia
and
liverdisease).
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intervals
ofodds
ratios
presented
in
Table
A
.2
O
S
D
B
B
C
H
L
C
C
C
D
H
F
D
P
A
T
SK
T
D
K
D
O
P
D
T
M
P
SP
C
P
L
D
U
P
H
T
[3.1-3.9]
[5.2-6.2]
[1.6-2]
[6.6-7.7]
[2-2.5]
[6.9-8.3]
[2.7-4.2]
[1.4-1.8]
[3.6-4.4]
[5.1-8.7]
[2.4-2.9]
[7.9-14.2]
[2.9-3.8]
[1.8-3.2]
[1.7-2.0]
[1.2-1.6]
[1.7-2.3]
[1.3-4.6]
[2.7-3.5]
O
S
-
[3.2-4.3]
[1.4-1.9]
[2.9-3.7]
[1.3-1.9]
[3-3.9]
[1.5-3.1]
[1.8-2.5]
[2-2.8]
[0.7-2.2]
[1.5-2.2]
[1.6-3.9]
[1.3-2.1]
[0.4-1.7]
[1.6-2.2]
[0.4-0.9]
[1.7-2.6]
[0.4-4.5]
[1.8-2.9]
D
B
-
-
[1.1-1.5]
[4.6-5.6]
[1.7-2.2]
[3.2-3.9]
[3.1-5.2]
[0.9-1.3]
[2.2-2.8]
[2.2-4.2]
[1.5-2.1]
[4.1-7.3]
[1.2-1.9]
[1.6-3.3]
[1.1-1.5]
[1.2-1.9]
[1.4-2]
[2.4-8.6]
[1.7-2.5]
B
C
-
-
-
[1.6-2]
[1.1-1.5]
[2.5-3.2]
[1.6-2.9]
[2.4-3.0]
[1.8-2.3]
[1.4-2.8]
[1.5-1.9]
[1.4-2.8]
[1.3-1.9]
[0.9-2.0]
[2.8-3.5]
[1-1.5]
[1.6-2.2]
[0.4-2.8]
[1.4-2]
H
L
-
-
-
-
[1.8-2.3]
[6.6-8]
[2.4-3.9]
[1.7-2.1]
[3.1-3.9]
[3.6-6.2]
[2.4-3.1]
[4.1-7.1]
[3.2-4.2]
[1.5-2.9]
[2-2.5]
[1.9-2.6]
[1.8-2.4]
[0.4-2.5]
[3.5-4.6]
C
C
-
-
-
-
-
[1.9-2.5]
[2.0-3.8]
[1-1.4]
[2-2.7]
[1.9-4]
[1.5-2.2]
[2.7-5.4]
[2.9-4.1]
[1.2-2.8]
[1.5-2]
[1.2-1.9]
[2.1-2.9]
[0.3-3.5]
[2-3.1]
C
D
-
-
-
-
-
-
[7.1-11.2]
[2.6-3.3]
[3.4-4.4]
[4.4-7.7]
[2.3-3]
[6.5-11.2]
[2.5-3.5]
[2.3-4.4]
[2.9-3.6]
[1.1-1.7]
[1.9-2.6]
[1.7-6.5]
[3.8-5.2]
H
F
-
-
-
-
-
-
-
[0.7-1.7]
[3-5.3]
[2.3-8]
[1.6-3.2]
[7-17.1]
[2.4-5]
[1.1-5.7]
[0.9-1.8]
[0.9-2.6]
[1.2-2.8]
[1.9-19.5]
[1.4-3.4]
D
P
-
-
-
-
-
-
-
-
[1.2-1.7]
[0.6-1.6]
[1.5-2.2]
[1.1-2.6]
[1.6-2.4]
[0.8-2.1]
[3-3.8]
[1.2-1.9]
[2.1-2.9]
[0.7-4.4]
[1.5-2.4]
A
T
-
-
-
-
-
-
-
-
-
[1.8-3.7]
[2.2-2.9]
[3.2-6.1]
[3.4-4.7]
[1.8-3.7]
[2.4-3.1]
[1.8-2.8]
[2.4-3.4]
[0.5-3.8]
[2-3]
SK
-
-
-
-
-
-
-
-
-
-
[0.8-2.2]
[2.6-10]
[3.3-6.9]
[4.8-14.7]
[1.1-2.3]
[0.6-2.3]
[1.7-3.9]
[0-0]
[2-4.9]
T
D
-
-
-
-
-
-
-
-
-
-
-
[2.4-5]
[3.1-4.4]
[0.9-2.5]
[1.8-2.4]
[1.4-2.3]
[1.8-2.6]
[0.2-3.1]
[1.2-1.9]
K
D
-
-
-
-
-
-
-
-
-
-
-
-
[3.5-7.5]
[2.4-10.2]
[1.1-2.5]
[1.4-4.1]
[2.7-5.7]
[0.4-20.1]
[3.8-8.1]
O
P
-
-
-
-
-
-
-
-
-
-
-
-
-
[1.8-4.6]
[2-2.9]
[1.4-2.6]
[3.1-4.5]
[0.3-5.2]
[1.5-2.6]
D
T
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[0.5-1.5]
[0.4-2]
[0.5-1.9]
[0.4-20.3]
[0.9-3]
M
P
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[1.2-1.8]
[2.6-3.5]
[0.1-2.1]
[1.9-2.7]
SP
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[1.2-2.1]
[0.4-6]
[1-2]
C
P
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[0.5-4.7]
[2.1-3.3]
L
D
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[0.1-4.8]
U
P
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Table
A
.3:
95%
confidence
intervals
(C
I)
for
all
disease
pairs
to
estim
ate
the
precision
of
the
odds
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indicates
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precision
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odds
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a
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all
C
I
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precision
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odds
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C
I
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green
highlights
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cells
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higher
association
forcorresponding
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triples
to
co-occur.
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Figure A.3: Disease correlations of two coexisting diseases for female patients. The diameter
of each circle represents the relative percentage of occurrence of the corresponding disease pair
among females population.
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Figure A.4: Disease correlations of two coexisting diseases for male patients. The diameter of
each circle represents the relative percentage of occurrence of the corresponding disease pair
among males population.
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Figure A.5: Disease correlations of two coexisting diseases among children. The diameter of
each circle represents the relative percentage of occurrence of the corresponding disease pair
among children’s population. There are nine patients in the database under child age group
who are diagnosed with two diseases. Obesity, bronchitis and colon problem form the majority
of disease combinations among children. The disease combination of bronchitis and colon
problem is most commonly occurring disease pair affecting 3 children. The family income
level of all patients in this age group belongs to high or highest income quintiles.
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Figure A.6: Disease correlations of two coexisting diseases for adolescent. The diameter of
each circle represents the relative percentage of occurrence of the corresponding disease pair
among adolescent. Bronchitis is the dominant disease which coexists with many other chronic
conditions among adolescent, and it correlates with a wider variety of diseases in adolescent
compared to children. The family income level of all patients in this age group belongs to high
or highest income quintiles.
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Figure A.7: Disease correlations of two coexisting diseases for young adults. The diameter of
each circle represents the relative percentage of occurrence of the corresponding disease pair
among young adults. Coexistence of hypertension with other chronic conditions starts to ap-
pear among patients from this age group. Bronchitis is still one of the dominant diseases mostly
co-occurring with depression and musculoskeletal problem among young adults. Depression
and obesity become the two other dominant diseases coexisting with a variety of chronic con-
ditions. Correlation of thyroid problem with some chronic diseases starts to appear from this
age group.
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Figure A.8: Disease correlations of two coexisting diseases for adult patients. The diameter of
each circle represents the relative percentage of occurrence of the corresponding disease pair
among adults population. Bronchitis is still on the list of dominant diseases for this age group,
coexisting with eleven other chronic conditions. Musculoskeletal problem becomes another
dominant disease coexisting with ten chronic conditions. Hypertension correlates with many
other chronic conditions in this age group and depression becomes less dominant compared to
young adults age group.
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Figure A.9: Disease correlations of two coexisting diseases for middle age patients. The diam-
eter of each circle represents the relative percentage of occurrence of the corresponding disease
pair among middle aged patients. The variety of disease correlations become relatively larger
compared to adults. Hypertension and musculoskeletal problem become two dominant dis-
eases, coexisting with seventeen and eleven other chronic conditions respectively. Prevalence
of coexistence of cancer with other conditions is greater compared to adults.
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Figure A.10: Disease correlations of two coexisting diseases for elder patients. The diameter
of each circle represents the relative percentage of occurrence of the corresponding disease pair
among elder population. Hypertension becomes the most prevalent disease and co-occurs with
all other chronic conditions.
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Figure A.11: Disease correlations of two coexisting diseases for patients belonging to moderate
income quintile. The diameter of each circle represents the relative percentage of occurrence
of the corresponding disease pairs. The most dominant disease correlation belongs to the pair
of musculoskeletal problem and bronchitis. The pattern of disease correlations among patients
with socioeconomic score 3, is different from those who belong to group of socioeconomic
score 4 or 5, and the reason is small population of patients belonging to socioeconomic score
3.
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Figure A.12: Disease correlations of two coexisting diseases for patients belonging to high
income quintile. The diameter of each circle represents the relative percentage of occurrence
of the corresponding disease pairs.
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Figure A.13: Disease correlations of two coexisting diseases for patients belonging to highest
income quintile. The diameter of each circle represents the relative percentage of occurrence
of the corresponding disease pairs.
Appendix B
Modified K-modes Clustering Results
This appendix includes the clustering results of patient socio-demographic characteristics for
patients who are diagnosed with the same two chronic conditions.
Figure B.1: Clusters of patients with depression and musculoskeletal problem. The clusters
have appeared based on gender split. Every clusters represents the patients belonging to a
few consecutive age groups and socioeconomic scores, which are mainly male or female. The
second clusters holds the most patients who belong to all socioeconomic groups, are between
age group 3 and 6, and are mainly male, while forth cluster specifies middle aged patients who
belong to highest income quintile and are mainly female.
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Figure B.2: Clusters of patients with hypertension and musculoskeletal problem. The data
split occurs according to the three attributes age, gender and socioeconomic score. The second
cluster refers to female patients who belong to socioeconomic score 4, while the third cluster
refers to elder male patients of the same socioeconomic score.
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Figure B.3: Clusters of patients with hypertension and diabetes. The clusters split the data over
age group and gender. Cluster 1 belongs to patients of socioeconomic score 4 and 5, who are
either adult or middle aged, while clusters 2 and 3 belong to elder female and male patients
respectively.
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Figure B.4: Clusters of patients with cancer and musculoskeletal problem. Clusters mainly
appear over socioeconomic score and gender. Cluster 1 belongs to female patients of 4 age
groups who belong to highest income quintile, while clusters 2 and 3 refer to patients with
high socioeconomic quintile and split males from females.
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Figure B.5: Clusters of patients with cancer and depression. This disease pair mainly affects
females according to out dataset. Clusters divide patients of different age groups and males of
elder age group from elder females.
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Figure B.6: Clusters of patients with hypertension and depression. Clusters divide the patients
over gender and age group. Females of age group 5 and 6 are clustered in clusters 3 and 2
respectively, while most of the male patients who have this disease combination are clustered
in cluster 1.
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Figure B.7: Clusters of patients with hypertension and cancer. Clusters clearly appear over
gender and socioeconomic score split. Patients from highest income quintiles are clustered
separately from patients from high income quintile. Male and females who belong to socioe-
conomic score 4, have been divided into two clusters.
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Figure B.8: Clusters of patients with hyperlipidemia and musculoskeletal problem. Clusters
mainly divide the patients by gender and age group. However, this is not a perfect split of
patients based on demographic characteristics.
117
Figure B.9: Clusters of patients with bronchitis and musculoskeletal problem. Patients distri-
bution over age groups and socioeconomic scores is similar to patients with depression and
musculoskeletal problem. The division of patients into clusters is also similar in these two
disease pairs. There are five clusters dividing the data: other than cluster 2 which mainly di-
vides males from females, the other clusters belong to patients of one to three consecutive age
groups.
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